data_2d56_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2d56 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.03 -31.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.38 66.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -91.76 -25.53 19.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.48 -34.05 88.1 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.404 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.74 -41.37 15.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.279 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -34.15 75.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.62 -46.88 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.189 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -47.66 79.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.069 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.4 p -60.33 -48.96 79.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 m -73.22 -17.14 61.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.457 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -83.17 -23.03 33.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.92 -31.55 17.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -78.45 -15.26 58.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 m120 67.11 28.15 8.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.0 25.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.63 109.62 0.4 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.057 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.422 HG22 ' CD2' ' A' ' 36' ' ' HIS . 8.9 t -97.39 130.41 44.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.89 125.13 6.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.632 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 34' ' ' THR . 39.1 m-70 -131.37 133.45 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.775 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.26 92.35 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -89.11 89.97 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 147.74 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -135.21 -80.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.958 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 23.78 19.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.749 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.7 24.53 7.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.405 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 87.89 25.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 109.07 2.39 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.567 2.178 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -107.17 147.91 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.5 t -109.44 87.97 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.22 133.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -121.89 111.74 17.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -159.99 115.62 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.427 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 tpt180 -160.62 37.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.976 0.417 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.72 -33.54 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.725 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -25.87 68.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.169 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -92.26 -25.96 18.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -31.73 65.68 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.566 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -85.88 -39.82 16.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.49 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -34.96 79.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.435 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 tp -77.03 -46.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -66.45 -47.63 72.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.216 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -61.43 -45.54 93.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.285 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.53 -17.84 59.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.508 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -23.34 34.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 111.061 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.75 -39.12 67.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.23 -15.51 62.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 64.56 29.41 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.99 25.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 112.09 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.072 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' CE1' ' A' ' 36' ' ' HIS . 12.6 t -101.5 123.03 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.278 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.79 132.18 11.17 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.76 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.406 ' CE1' HG22 ' A' ' 34' ' ' THR . 20.7 m80 -141.3 142.4 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.4 p -79.98 88.85 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.55 168.92 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.96 132.48 18.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.32 -85.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 40.28 3.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.407 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.77 29.13 39.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.086 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.84 142.66 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.248 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.66 157.46 60.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.422 2.081 . . . . 0.0 112.414 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -151.5 139.15 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.62 83.38 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.94 117.11 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 78.9 m -113.22 106.12 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.98 117.95 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.546 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 52.7 ttt-85 -160.5 35.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.939 0.4 . . . . 0.0 110.937 -179.956 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tptt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.837 0.351 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 t -71.36 -29.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.14 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.71 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -90.59 -20.47 22.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.11 -34.58 58.24 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.701 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.79 -39.52 18.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.557 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -39.45 94.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.97 0.414 . . . . 0.0 110.293 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.1 tp -71.49 -49.34 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.499 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.1 p -63.04 -50.19 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -56.0 -38.25 70.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.1 m -84.68 -10.23 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -85.58 -26.18 26.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -29.45 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -83.11 -16.83 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.356 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.66 28.51 17.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.725 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -152.71 25.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.52 110.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.997 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.406 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.2 t -100.8 124.41 46.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.376 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.97 133.37 12.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 143.35 30.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.91 97.05 6.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -96.16 130.77 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 127.05 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -118.41 -81.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.08 3.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.29 31.85 68.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.089 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 108.65 7.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.532 0.206 . . . . 0.0 111.156 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.14 148.4 39.43 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.44 2.093 . . . . 0.0 112.388 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -141.25 175.7 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.1 t -116.91 85.9 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.85 121.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.3 m -114.33 109.33 18.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -158.92 118.21 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.394 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HB2' ' N ' ' A' ' 34' ' ' THR . 6.6 ttt-85 -160.53 34.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.5 t -64.88 -42.15 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -22.83 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -91.51 -23.85 19.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.45 -33.0 59.14 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.57 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.63 -38.82 19.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.398 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -37.33 86.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.392 . . . . 0.0 110.506 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 7.3 tp -72.97 -49.39 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.558 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -49.39 66.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 0.0 111.15 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -54.85 -43.64 73.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.2 m -86.56 -6.32 58.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.526 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtpt -84.47 -26.5 28.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -38.76 57.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.28 -18.74 63.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.353 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 65.14 30.87 11.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.759 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.48 29.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 114.63 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.007 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 10.9 t -102.66 128.67 49.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 132.56 11.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -141.39 124.73 16.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.638 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.9 p -79.93 93.71 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.27 174.55 5.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 126.39 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.28 -85.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.923 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 40.94 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.207 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.01 30.41 42.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.928 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 95.49 37.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.644 0.259 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 120.74 8.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.465 2.11 . . . . 0.0 112.144 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 m -124.91 158.09 34.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.73 94.58 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -79.98 130.68 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.0 m -121.0 103.87 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -156.95 119.21 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.424 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 33.8 ttt-85 -160.6 36.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.191 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.743 0.306 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 t -60.52 -38.87 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.73 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.054 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -91.73 -24.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.32 -34.74 75.21 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.569 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.62 -41.59 16.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.219 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.73 -36.03 82.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.3 tp -74.28 -46.13 45.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.326 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 t -66.04 -51.52 57.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -57.29 -40.3 77.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.279 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.67 -10.61 57.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.667 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -83.56 -27.63 29.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 110.708 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.17 -26.69 29.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.01 -14.72 40.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.49 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 58.36 26.05 13.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.58 21.84 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.55 109.37 0.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.957 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.412 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 12.6 t -98.28 123.24 42.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.413 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.87 111.72 3.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.578 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -118.65 150.08 40.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.5 p -83.92 83.59 7.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 -176.08 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.98 139.87 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -118.47 -86.77 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.36 29.58 6.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.402 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.06 27.94 10.45 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.116 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.72 147.35 59.08 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.659 0.266 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 147.3 82.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.164 . . . . 0.0 112.392 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -138.19 151.51 47.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.805 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -105.88 79.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 m -80.84 121.81 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.7 m -113.68 108.85 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.2 116.96 3.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.583 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.413 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 32.7 ttt85 -160.47 33.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.984 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 110.948 -179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.905 0.384 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.14 -41.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.33 -24.22 66.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.005 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.71 -23.18 19.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.82 -33.4 60.2 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.581 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -85.68 -41.35 15.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.314 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.13 -35.85 79.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.47 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.76 -47.2 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 p -62.65 -52.76 62.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 p -55.84 -47.0 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.394 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.5 m -78.07 -8.12 57.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.716 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.42 23.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.672 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -50.84 -26.7 6.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.12 -14.38 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.379 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 63.5 32.31 14.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.807 0.337 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -160.76 28.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.61 112.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.033 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.414 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 8.9 t -101.22 135.0 43.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 132.16 11.15 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.764 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -141.64 140.19 33.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.1 p -79.91 89.68 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.982 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.63 106.94 19.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.61 160.02 26.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -142.99 -80.29 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.27 39.31 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.613 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.24 26.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.65 98.92 27.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 111.033 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 91.95 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.475 2.117 . . . . 0.0 112.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -86.42 145.43 26.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.09 90.99 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -79.98 140.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.33 110.09 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -160.14 117.55 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.4 ttt85 -160.27 33.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.204 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.876 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.41 -33.89 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.13 69.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.196 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -91.66 -24.45 19.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.53 -31.78 71.08 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.603 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -86.28 -44.7 11.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.269 -0.466 . . . . 0.0 110.545 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.8 72.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.608 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.11 -45.32 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.227 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.3 p -62.41 -49.81 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.3 m -63.21 -47.48 82.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.367 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.16 -20.78 64.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -87.39 -19.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.693 0.283 . . . . 0.0 111.222 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.256 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -80.19 -12.49 59.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.92 32.5 13.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.867 0.365 . . . . 0.0 110.823 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -159.72 28.11 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.5 112.1 0.51 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.993 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.407 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.2 t -96.81 129.84 44.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.96 138.81 20.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.69 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.82 150.38 27.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.688 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 p -92.98 78.19 4.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 -170.07 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 142.46 23.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -81.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.29 35.17 3.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.412 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 29.68 23.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.122 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -148.18 147.17 25.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.291 . . . . 0.0 111.06 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.99 162.39 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.619 2.213 . . . . 0.0 112.328 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -154.42 143.44 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.9 79.78 4.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.96 136.23 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.4 m -133.6 108.34 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.01 117.12 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -160.64 39.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.041 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.914 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tptt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -31.14 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.019 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.48 -27.35 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -23.46 20.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -32.58 62.6 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.526 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.72 -42.01 17.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -37.78 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.531 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 8.3 tp -71.06 -47.62 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.527 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -67.13 -50.85 59.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -52.62 -42.29 64.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -84.81 -13.27 51.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.322 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.23 -25.46 51.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.735 0.303 . . . . 0.0 110.785 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -39.62 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.32 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.0 -18.23 60.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.276 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.07 31.95 10.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 m -159.26 26.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.082 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.64 109.69 0.41 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.35 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -97.68 126.28 42.93 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.87 135.08 14.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.805 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -149.33 135.99 19.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.95 102.67 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -105.47 133.33 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -120.65 112.71 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -97.12 -81.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.731 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 22.33 27.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.316 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.93 5.47 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.055 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -132.27 109.31 13.75 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.595 0.236 . . . . 0.0 111.055 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 87.82 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 t -86.8 164.72 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 89.09 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.95 134.95 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.3 m -121.04 113.1 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.994 0.426 . . . . 0.0 111.384 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -159.77 116.14 2.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.638 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.2 tpt180 -160.68 39.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.08 -32.67 33.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.43 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.978 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -93.41 -24.71 17.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -67.65 -36.3 87.56 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.338 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -85.76 -40.38 16.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.981 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.99 -35.49 80.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.25 -45.08 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 -43.96 98.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.68 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -44.52 97.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.2 m -71.51 -28.84 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -75.97 -20.21 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.559 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.82 -25.73 4.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -96.06 -10.56 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.613 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m120 66.29 33.3 7.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.042 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -163.8 30.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.74 114.3 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.117 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 50' ' ' ARG . 9.1 t -98.42 140.2 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 114.21 3.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.619 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -121.33 130.45 53.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.06 96.44 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.84 132.52 38.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.28 118.16 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -104.2 -81.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.26 43.44 2.93 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.86 47.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.299 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -122.71 89.41 50.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.45 153.09 70.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -160.03 171.68 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.1 m -126.22 108.83 11.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.798 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 m -98.75 148.97 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -116.37 100.88 8.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.761 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.23 106.16 3.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -160.69 42.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.781 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 -179.848 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.76 -31.12 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.43 70.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -91.47 -22.37 20.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.06 -30.83 64.86 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.575 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.58 -42.91 13.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.306 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.31 -45.4 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -61.74 -51.46 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 111.098 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 p -58.34 -49.97 75.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 m -70.9 -14.91 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -86.13 -23.66 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.28 -28.51 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.29 -17.14 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.355 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.76 26.64 13.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -154.98 26.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.423 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.6 110.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.921 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.411 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 9.9 t -95.86 128.22 42.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.03 125.5 6.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.757 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.8 133.96 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.613 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.19 92.41 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.058 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.7 115.58 22.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.3 115.13 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -81.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.715 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.21 39.73 3.08 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.278 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.01 31.87 33.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -132.07 89.2 38.71 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.64 148.7 90.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.592 2.195 . . . . 0.0 112.134 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -142.16 137.77 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.89 78.5 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.93 133.61 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 39.0 m -124.24 107.43 11.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.25 116.47 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.423 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 8.9 ttt85 -160.5 34.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -76.39 -33.02 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.57 -23.67 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.91 -25.17 18.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.67 64.56 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.408 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.35 -39.88 18.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.115 -0.543 . . . . 0.0 110.214 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.61 -39.93 95.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.324 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.5 tp -70.16 -47.92 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.357 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 m -64.72 -56.16 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.306 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -31.62 63.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -90.43 -12.12 38.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -83.14 -27.67 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.599 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.06 -29.03 69.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.99 -7.4 53.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.501 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 m120 50.92 32.46 7.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 111.565 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -166.3 31.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 114.71 0.62 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.144 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 50' ' ' ARG . 10.6 t -102.49 128.95 48.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.62 126.63 7.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.769 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.1 129.8 42.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.335 . . . . 0.0 110.602 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.23 92.44 8.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -84.02 157.64 21.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -158.81 116.08 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -106.79 -82.97 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.33 32.8 4.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.244 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.18 30.78 13.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.092 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 116.11 30.02 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.607 0.241 . . . . 0.0 110.949 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 105.61 2.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.487 2.124 . . . . 0.0 112.299 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -93.73 141.67 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 82.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.53 161.52 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.7 m -155.77 106.73 2.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.21 120.36 2.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.44 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 ttt-85 -160.61 40.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.733 0.302 . . . . 0.0 111.252 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.867 0.365 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.91 -31.5 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.47 70.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -91.76 -24.16 19.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.04 -31.13 64.54 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.482 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.69 -40.69 15.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.37 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -36.15 82.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.359 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.52 -47.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.628 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -65.79 -46.64 77.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -59.38 -47.0 87.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.356 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.1 -14.47 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.529 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -82.31 -25.24 34.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.96 -29.72 43.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.268 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -13.88 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.441 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m120 58.87 25.1 13.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -148.56 21.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 110.88 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.055 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.425 HG22 ' CD2' ' A' ' 36' ' ' HIS . 11.8 t -97.79 126.87 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.653 0.263 . . . . 0.0 110.367 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 130.95 10.18 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.609 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.425 ' CD2' HG22 ' A' ' 34' ' ' THR . 57.2 m-70 -141.41 152.57 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.9 m -79.95 88.52 5.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.004 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.86 94.65 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 131.85 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -77.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.22 25.45 12.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 32.77 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.322 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 81.91 14.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.702 0.287 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.22 107.29 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.616 2.211 . . . . 0.0 112.094 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 m -120.32 155.92 32.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 88.9 2.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.97 125.57 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.2 m -117.62 107.23 13.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -154.05 116.03 4.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.418 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 35.4 ttt180 -160.16 28.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.878 0.37 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.93 -32.78 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -25.11 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -92.86 -24.71 18.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.84 -34.48 62.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.443 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.81 -40.24 17.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.356 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.9 -35.7 81.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.44 -46.93 36.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.545 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -51.1 60.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.338 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 t -60.0 -39.8 87.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.9 m -82.24 -16.44 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -80.14 -27.65 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.642 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.61 -27.61 67.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.299 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.18 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.556 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.19 31.91 2.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.839 0.352 . . . . 0.0 111.667 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.73 29.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.82 114.24 0.6 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.009 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.422 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 12.7 t -104.28 123.84 48.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.909 0.354 . . . . 0.0 110.397 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 103.33 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -112.73 142.83 44.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.326 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.6 p -81.48 86.41 6.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -167.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -159.58 120.88 3.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -98.71 -86.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 28.12 7.8 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.381 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.58 8.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.107 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.93 139.88 20.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.642 0.258 . . . . 0.0 111.012 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.74 144.59 42.73 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.568 2.179 . . . . 0.0 112.408 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -133.19 141.52 48.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.776 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.12 74.17 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.88 125.98 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.5 m -119.75 108.14 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 111.374 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -160.0 119.7 2.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.602 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.8 ttt85 -160.56 39.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 -179.885 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tttt . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.807 0.337 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.55 -38.4 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.078 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -92.4 -21.99 19.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.08 -33.5 59.39 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.49 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.91 -42.35 15.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.093 -0.553 . . . . 0.0 110.375 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -37.04 82.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.76 -49.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.229 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -62.3 -52.13 64.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.3 p -53.87 -44.55 70.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.55 -8.28 59.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.56 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -85.1 -26.63 26.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -50.4 -26.61 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.483 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -86.23 -17.34 35.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.61 33.6 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 m -161.0 29.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.6 113.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.005 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.43 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.0 t -101.51 129.95 47.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 135.76 15.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.544 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 148.49 25.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.05 97.31 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -110.27 145.97 36.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 148.39 51.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.3 -81.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.33 48.68 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.897 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.37 31.04 76.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.976 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.91 124.84 14.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.491 0.186 . . . . 0.0 111.136 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.04 154.11 34.96 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.426 2.084 . . . . 0.0 112.223 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.8 m -158.04 155.4 29.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.16 91.56 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.9 136.22 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -128.56 106.86 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.69 119.04 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt85 -160.42 35.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.331 . . . . 0.0 111.064 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.872 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.76 -43.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.726 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.74 -22.16 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.059 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -90.79 -25.74 19.8 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.97 -33.82 70.45 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.504 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.01 -38.07 21.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.394 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -38.16 86.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.429 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 7.3 tp -70.97 -49.44 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.49 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -67.63 -49.7 61.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.796 0.332 . . . . 0.0 111.053 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.2 t -53.08 -41.46 64.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.223 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m -87.01 -10.36 53.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.3 mtpt -79.81 -26.5 40.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 0.0 110.975 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -38.16 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.41 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -72.27 -14.59 61.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 t30 59.24 27.49 16.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 22.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.11 114.23 0.6 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.144 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 t -101.44 129.16 47.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.73 120.68 5.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.669 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.4 139.5 53.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 110.679 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 p -90.42 88.46 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.66 143.54 27.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.745 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -143.66 128.07 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -110.57 -82.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.28 35.5 3.8 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.55 22.24 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.167 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -131.27 116.01 16.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.192 . . . . 0.0 110.996 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.31 156.7 50.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.388 2.059 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.4 m -147.5 148.72 31.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.5 t -105.93 79.94 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.962 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.7 m -79.93 129.14 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.686 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m -117.57 106.53 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.019 0.438 . . . . 0.0 111.501 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.25 115.49 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.239 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -160.58 53.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 111.232 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 mttt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.07 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.42 -29.56 68.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -91.41 -22.19 20.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.39 62.51 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.554 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.1 -42.65 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.18 -0.51 . . . . 0.0 110.432 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -41.24 97.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.32 -47.39 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.455 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.5 t -62.97 -53.89 46.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -53.24 -37.14 61.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 1.2 m -82.61 -17.53 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.305 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -22.98 42.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -31.23 16.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.517 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -85.51 -18.61 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.685 0.279 . . . . 0.0 111.486 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 t30 66.42 29.53 9.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.893 0.378 . . . . 0.0 110.962 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.61 29.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.62 122.17 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.542 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.444 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 14.9 t -110.68 135.19 51.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 110.245 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.6 108.81 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.685 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -115.65 139.94 49.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 0.0 110.663 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.02 89.49 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.55 168.04 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -145.28 109.84 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -86.17 -85.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.773 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.3 24.66 15.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.384 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.22 29.85 6.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.059 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -127.55 117.7 21.31 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.98 94.18 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.469 2.113 . . . . 0.0 112.183 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.5 m -99.62 155.06 17.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.3 t -108.12 100.46 9.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.7 m -79.95 143.12 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t -118.18 99.06 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.132 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -160.16 119.61 2.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.739 0.304 . . . . 0.0 111.675 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 7.2 ttt85 -160.6 28.73 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.952 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.21 -32.96 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.88 -30.35 61.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -92.82 -22.83 19.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.27 -34.34 64.2 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.58 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -85.32 -41.74 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.236 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 1.3 m -62.74 -36.24 82.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.419 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 tp -75.39 -44.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.178 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.0 p -59.67 -56.86 16.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.81 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t -55.91 -42.19 75.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 m -70.23 -22.02 62.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -77.82 -26.89 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.94 -33.73 64.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 15.7 pt20 -87.0 -20.12 27.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 76.32 -41.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.74 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.31 36.5 0.79 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.655 0.264 . . . . 0.0 111.15 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.79 122.57 1.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.085 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 50' ' ' ARG . 6.7 t -103.25 130.06 50.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.91 111.76 4.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -132.17 159.32 39.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.1 t -95.26 93.39 7.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -173.91 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.41 132.79 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -108.35 -85.2 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.34 43.72 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.276 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.22 29.47 56.4 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.982 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.87 148.88 71.21 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.716 0.293 . . . . 0.0 110.992 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 133.99 22.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.605 2.203 . . . . 0.0 112.406 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 m -138.21 157.19 46.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.65 98.44 6.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 145.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 t -131.33 97.88 4.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.97 121.77 3.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.602 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 24.4 ttp180 -160.03 28.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.869 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 t -83.15 -34.09 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -26.23 66.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -31.92 14.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.81 -32.76 83.85 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.586 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -84.99 -41.6 15.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.361 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.1 -34.82 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.0 tp -75.49 -46.74 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.475 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.8 m -66.97 -48.0 69.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.232 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -60.64 -42.34 96.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.585 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m -82.47 -14.71 54.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.759 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -26.86 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -24.61 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.427 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -17.21 34.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.437 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.0 30.33 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -157.61 27.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 113.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.027 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.441 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.7 t -97.86 128.66 44.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 129.55 9.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.825 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -141.48 118.35 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.634 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.7 p -80.0 94.35 5.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 171.4 9.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.57 131.55 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -87.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.46 25.99 11.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.376 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 28.27 7.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 124.67 26.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.516 0.198 . . . . 0.0 111.048 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.56 86.73 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 m -80.06 145.25 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 89.89 3.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -80.01 162.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 34' ' ' THR . 80.2 m -152.52 109.11 3.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -160.0 119.06 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.441 ' HB2' ' N ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -160.54 35.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.897 0.38 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -83.9 -34.06 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.88 -36.35 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -90.75 -21.03 21.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.5 -34.33 78.95 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.425 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -85.34 -42.2 14.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -34.17 76.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.18 -46.99 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.021 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.2 m -63.45 -48.81 76.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -57.4 -49.66 75.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.349 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.77 -13.33 60.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.83 -26.62 34.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -36.05 25.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -72.97 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.353 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 64.59 26.62 13.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -153.73 23.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.49 113.38 0.56 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.935 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.432 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 t -103.16 134.56 46.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.74 0.305 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.84 130.8 10.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.709 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.45 150.95 45.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.92 90.88 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.54 88.55 5.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 -178.46 5.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.56 -75.9 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.73 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 15.82 58.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.654 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 29.23 2.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -114.39 85.79 11.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.19 92.24 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.532 2.154 . . . . 0.0 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -98.76 144.57 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.68 94.02 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -83.11 126.06 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 83.9 m -116.8 104.5 11.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.02 116.0 4.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.634 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.8 ttp85 -160.41 28.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.051 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.842 0.353 . . . . 0.0 110.894 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 mttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.92 -37.11 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.95 69.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.233 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -23.33 19.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.51 -33.38 61.1 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.544 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.15 -42.74 15.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -41.23 96.3 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.367 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 tp -70.22 -47.86 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.69 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 p -63.65 -55.61 22.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 0.0 111.057 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -52.37 -37.97 57.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 3.7 m -80.44 -22.26 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.314 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.8 tptt -73.05 -26.06 61.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -56.25 -22.34 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.686 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -92.61 -9.87 39.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.56 30.07 16.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.197 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 31.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.34 125.52 1.45 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.837 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.495 ' HB ' ' HG3' ' A' ' 50' ' ' ARG . 9.9 t -116.87 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.687 0.28 . . . . 0.0 110.25 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.44 110.16 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.657 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -119.12 126.45 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 0.0 110.708 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.5 p -80.0 93.7 5.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.87 151.68 19.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.785 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 137.09 9.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.954 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -128.69 -82.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.06 46.95 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.9 31.59 59.88 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -126.69 89.05 53.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.15 124.39 9.5 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.629 2.22 . . . . 0.0 112.325 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.0 m -130.47 162.36 29.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 100.55 7.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.86 140.18 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.08 93.66 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.414 ' O ' ' CG2' ' A' ' 34' ' ' THR . 3.1 m-20 -160.35 121.8 3.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HG3' ' HB ' ' A' ' 34' ' ' THR . 3.7 tmm_? -161.1 60.9 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 m . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.836 0.351 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.42 97.59 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -90.31 85.85 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -151.33 -47.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -117.24 158.63 23.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -169.95 83.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.8 50.29 5.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.63 30.59 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 -33.42 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.4 ttm 61.44 30.93 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -94.24 -31.96 13.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -69.35 159.69 82.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.153 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.39 -35.76 36.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.697 2.265 . . . . 0.0 112.393 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -15.07 3.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.765 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.21 -19.75 61.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -25.54 27.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.263 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -44.14 69.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.03 -31.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.38 66.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -91.76 -25.53 19.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.48 -34.05 88.1 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.404 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.74 -41.37 15.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.279 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -34.15 75.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.592 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.62 -46.88 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.189 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -47.66 79.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.069 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.4 p -60.33 -48.96 79.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 m -73.22 -17.14 61.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.457 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -83.17 -23.03 33.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.92 -31.55 17.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -78.45 -15.26 58.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 m120 67.11 28.15 8.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.0 25.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.63 109.62 0.4 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.057 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.422 HG22 ' CD2' ' A' ' 36' ' ' HIS . 8.9 t -97.39 130.41 44.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.89 125.13 6.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.632 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 34' ' ' THR . 39.1 m-70 -131.37 133.45 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.775 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.26 92.35 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -89.11 89.97 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 147.74 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -135.21 -80.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.958 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 23.78 19.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.749 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.7 24.53 7.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.405 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 87.89 25.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 109.07 2.39 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.567 2.178 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -107.17 147.91 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.5 t -109.44 87.97 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.22 133.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -121.89 111.74 17.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -159.99 115.62 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.427 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 tpt180 -160.62 37.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.28 131.98 39.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.49 117.33 4.26 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.8 158.97 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 61.17 166.71 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -100.05 144.15 29.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.7 p -168.71 77.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -120.51 61.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 t -98.83 33.26 2.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.19 -34.35 15.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -137.06 28.27 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -41.79 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.53 35.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.636 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.63 111.87 22.5 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.316 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.6 -25.65 5.32 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.399 2.066 . . . . 0.0 112.117 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 44.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.372 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 t -46.66 -28.99 1.65 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.38 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -45.44 92.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.976 0.417 . . . . 0.0 110.568 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.72 -33.54 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.725 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -25.87 68.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.169 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -92.26 -25.96 18.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -31.73 65.68 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.566 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -85.88 -39.82 16.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.49 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -34.96 79.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.435 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 tp -77.03 -46.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -66.45 -47.63 72.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.216 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -61.43 -45.54 93.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.285 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.53 -17.84 59.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.508 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -23.34 34.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 111.061 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.75 -39.12 67.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.23 -15.51 62.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 64.56 29.41 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.99 25.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 112.09 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.072 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' CE1' ' A' ' 36' ' ' HIS . 12.6 t -101.5 123.03 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.278 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.79 132.18 11.17 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.76 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.406 ' CE1' HG22 ' A' ' 34' ' ' THR . 20.7 m80 -141.3 142.4 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.4 p -79.98 88.85 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.55 168.92 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.96 132.48 18.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.32 -85.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 40.28 3.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.407 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.77 29.13 39.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.086 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.84 142.66 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.248 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.66 157.46 60.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.422 2.081 . . . . 0.0 112.414 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -151.5 139.15 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.62 83.38 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.94 117.11 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 78.9 m -113.22 106.12 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.98 117.95 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.546 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 52.7 ttt-85 -160.5 35.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.83 54.57 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.939 0.4 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -114.15 1.2 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.898 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.804 0.335 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.74 -42.05 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -109.8 -38.22 5.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.38 90.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.86 -176.35 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -176.94 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 46.87 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.22 62.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -52.59 -52.96 52.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.09 42.76 15.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.04 -25.95 62.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -54.32 156.48 5.77 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.431 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.1 -31.8 22.3 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.785 2.323 . . . . 0.0 112.334 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.38 42.63 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.661 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -141.05 21.53 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.789 0.328 . . . . 0.0 111.253 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 p -53.5 -28.36 30.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.143 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -71.67 -51.51 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 t -71.36 -29.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.14 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.71 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -90.59 -20.47 22.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.11 -34.58 58.24 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.701 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.79 -39.52 18.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.557 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -39.45 94.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.97 0.414 . . . . 0.0 110.293 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.1 tp -71.49 -49.34 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.499 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.1 p -63.04 -50.19 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -56.0 -38.25 70.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.1 m -84.68 -10.23 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -85.58 -26.18 26.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -29.45 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -83.11 -16.83 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.356 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.66 28.51 17.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.725 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -152.71 25.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.52 110.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.997 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.406 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.2 t -100.8 124.41 46.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.376 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.97 133.37 12.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 143.35 30.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.91 97.05 6.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -96.16 130.77 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 127.05 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -118.41 -81.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.08 3.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.29 31.85 68.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.089 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 108.65 7.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.532 0.206 . . . . 0.0 111.156 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.14 148.4 39.43 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.44 2.093 . . . . 0.0 112.388 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -141.25 175.7 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.1 t -116.91 85.9 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.85 121.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.3 m -114.33 109.33 18.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -158.92 118.21 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.394 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HB2' ' N ' ' A' ' 34' ' ' THR . 6.6 ttt-85 -160.53 34.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -90.51 139.37 30.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.63 117.51 1.46 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.925 -179.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.847 0.356 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.07 59.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -134.04 38.68 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -158.47 35.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.31 146.15 24.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -126.38 -73.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 m -102.31 37.48 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.86 -29.02 64.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -59.09 -38.03 78.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 60.6 38.56 18.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.13 32.59 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 m -93.01 153.41 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.23 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.85 -33.79 95.42 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.715 2.276 . . . . 0.0 112.423 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' N ' HD11 ' A' ' 15' ' ' LEU . . . 140.19 42.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.961 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -154.23 25.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 0.0 110.941 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.8 p -78.9 -25.94 43.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.007 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -71.69 -56.65 5.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.5 t -64.88 -42.15 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -22.83 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -91.51 -23.85 19.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.45 -33.0 59.14 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.57 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.63 -38.82 19.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.398 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -37.33 86.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.392 . . . . 0.0 110.506 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 7.3 tp -72.97 -49.39 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.558 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -49.39 66.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 0.0 111.15 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -54.85 -43.64 73.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.2 m -86.56 -6.32 58.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.526 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtpt -84.47 -26.5 28.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -38.76 57.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.28 -18.74 63.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.353 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 65.14 30.87 11.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.759 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.48 29.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 114.63 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.007 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 10.9 t -102.66 128.67 49.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 132.56 11.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -141.39 124.73 16.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.638 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.9 p -79.93 93.71 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.27 174.55 5.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 126.39 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.28 -85.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.923 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 40.94 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.207 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.01 30.41 42.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.928 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 95.49 37.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.644 0.259 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 120.74 8.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.465 2.11 . . . . 0.0 112.144 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 m -124.91 158.09 34.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.73 94.58 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -79.98 130.68 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.0 m -121.0 103.87 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -156.95 119.21 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.424 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 33.8 ttt-85 -160.6 36.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.191 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.37 51.24 1.87 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.98 70.9 1.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.897 0.38 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.77 -49.86 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.059 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.17 32.78 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -106.03 -31.64 8.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -61.35 138.07 58.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -162.08 71.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t 59.01 20.69 8.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.07 27.85 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.73 -48.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 ttm 63.01 39.79 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -145.82 52.87 1.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.751 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.9 142.76 95.81 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 -43.35 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.15 . . . . 0.0 112.6 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 160.99 -23.3 0.24 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.925 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -9.98 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 111.412 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t -61.0 -27.34 68.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -51.49 11.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 t -60.52 -38.87 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.73 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.054 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -91.73 -24.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.32 -34.74 75.21 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.569 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.62 -41.59 16.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.219 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.73 -36.03 82.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.3 tp -74.28 -46.13 45.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.326 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 t -66.04 -51.52 57.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -57.29 -40.3 77.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.279 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.67 -10.61 57.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.667 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -83.56 -27.63 29.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 110.708 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.17 -26.69 29.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.01 -14.72 40.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.49 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 58.36 26.05 13.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.58 21.84 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.55 109.37 0.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.957 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.412 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 12.6 t -98.28 123.24 42.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.413 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.87 111.72 3.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.578 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -118.65 150.08 40.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.5 p -83.92 83.59 7.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 -176.08 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.98 139.87 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -118.47 -86.77 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.36 29.58 6.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.402 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.06 27.94 10.45 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.116 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.72 147.35 59.08 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.659 0.266 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 147.3 82.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.164 . . . . 0.0 112.392 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -138.19 151.51 47.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.805 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -105.88 79.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 m -80.84 121.81 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.7 m -113.68 108.85 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.2 116.96 3.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.583 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.413 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 32.7 ttt85 -160.47 33.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.984 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.92 47.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.71 -55.31 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.165 -0.922 . . . . 0.0 110.829 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.76 0.314 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.07 132.85 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -52.69 4.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.44 32.51 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 98.42 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.9 t -95.78 -28.73 14.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 t 63.44 22.25 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 54.24 24.14 4.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.619 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.75 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.9 ttt 66.52 47.95 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -123.07 34.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.99 155.34 84.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.09 -37.56 14.46 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.58 2.187 . . . . 0.0 112.397 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.42 -16.46 1.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.18 26.69 9.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -73.58 -25.25 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.002 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.21 -52.64 45.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.14 -41.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.33 -24.22 66.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.005 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.71 -23.18 19.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.82 -33.4 60.2 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.581 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -85.68 -41.35 15.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.314 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.13 -35.85 79.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.47 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.76 -47.2 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 p -62.65 -52.76 62.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 p -55.84 -47.0 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.394 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.5 m -78.07 -8.12 57.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.716 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.42 23.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.672 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -50.84 -26.7 6.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.12 -14.38 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.379 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 63.5 32.31 14.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.807 0.337 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -160.76 28.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.61 112.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.033 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.414 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 8.9 t -101.22 135.0 43.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 132.16 11.15 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.764 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -141.64 140.19 33.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.1 p -79.91 89.68 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.982 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.63 106.94 19.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.61 160.02 26.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -142.99 -80.29 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.27 39.31 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.613 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.24 26.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.65 98.92 27.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 111.033 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 91.95 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.475 2.117 . . . . 0.0 112.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -86.42 145.43 26.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.09 90.99 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -79.98 140.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.33 110.09 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -160.14 117.55 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.4 ttt85 -160.27 33.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.204 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.74 123.38 33.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.83 94.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.4 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 t 64.17 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.9 -58.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -179.48 37.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m 178.5 162.7 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.9 p -106.84 -37.49 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 m -70.52 -52.25 23.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.57 36.3 19.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.22 87.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mtm -81.32 -60.01 2.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -144.63 45.23 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.13 137.29 29.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.027 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.93 -73.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.602 2.202 . . . . 0.0 112.373 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.58 29.56 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.683 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 -1.1 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.591 0.234 . . . . 0.0 111.392 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 p -60.91 -28.04 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.651 0.262 . . . . 0.0 111.042 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -49.71 70.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.41 -33.89 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.13 69.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.196 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -91.66 -24.45 19.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.53 -31.78 71.08 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.603 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -86.28 -44.7 11.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.269 -0.466 . . . . 0.0 110.545 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -34.8 72.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.608 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.11 -45.32 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.227 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.3 p -62.41 -49.81 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.3 m -63.21 -47.48 82.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.367 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.16 -20.78 64.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -87.39 -19.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.693 0.283 . . . . 0.0 111.222 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.256 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -80.19 -12.49 59.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.92 32.5 13.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.867 0.365 . . . . 0.0 110.823 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -159.72 28.11 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.5 112.1 0.51 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.993 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.407 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.2 t -96.81 129.84 44.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.96 138.81 20.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.69 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.82 150.38 27.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.688 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 p -92.98 78.19 4.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 -170.07 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 142.46 23.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -81.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.29 35.17 3.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.412 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 29.68 23.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.122 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -148.18 147.17 25.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.291 . . . . 0.0 111.06 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.99 162.39 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.619 2.213 . . . . 0.0 112.328 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -154.42 143.44 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.9 79.78 4.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.96 136.23 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.4 m -133.6 108.34 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.01 117.12 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -160.64 39.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.041 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -95.73 119.14 33.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.07 -65.16 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.821 0.344 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.45 144.08 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -61.35 141.78 57.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 60.11 160.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -101.43 94.26 5.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.04 27.08 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t 57.51 27.37 13.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 49.35 27.59 2.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.302 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.45 -62.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.4 ttt 54.81 26.8 8.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.96 -15.91 20.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 m -116.21 70.47 4.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 111.099 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 57.91 5.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.67 2.246 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.96 -57.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -26.4 14.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -54.67 -27.48 40.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -75.32 -45.4 39.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.805 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -31.14 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.019 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.48 -27.35 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -23.46 20.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -32.58 62.6 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.526 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.72 -42.01 17.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -37.78 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.531 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 8.3 tp -71.06 -47.62 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.527 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -67.13 -50.85 59.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -52.62 -42.29 64.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -84.81 -13.27 51.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.322 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.23 -25.46 51.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.735 0.303 . . . . 0.0 110.785 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -39.62 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.32 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.0 -18.23 60.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.276 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.07 31.95 10.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 m -159.26 26.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.082 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.64 109.69 0.41 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.35 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -97.68 126.28 42.93 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.87 135.08 14.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.805 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -149.33 135.99 19.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.95 102.67 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -105.47 133.33 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -120.65 112.71 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -97.12 -81.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.731 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 22.33 27.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.316 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.93 5.47 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.055 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -132.27 109.31 13.75 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.595 0.236 . . . . 0.0 111.055 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 87.82 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 t -86.8 164.72 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 89.09 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.95 134.95 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.3 m -121.04 113.1 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.994 0.426 . . . . 0.0 111.384 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -159.77 116.14 2.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.638 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.2 tpt180 -160.68 39.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -93.63 88.59 5.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.4 162.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.705 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.841 0.353 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -163.23 43.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.26 107.35 18.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -118.18 -51.66 2.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.92 176.69 9.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 p -113.77 -55.73 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 m -97.85 38.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.58 34.79 1.77 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.27 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.41 -33.9 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 mtp 60.08 35.81 21.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -111.25 29.16 8.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 m -159.56 55.0 0.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.54 56.05 5.41 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.686 2.258 . . . . 0.0 112.466 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.27 -17.59 2.95 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.945 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -33.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -45.43 -29.48 1.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.321 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -48.24 76.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.08 -32.67 33.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.43 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.978 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -93.41 -24.71 17.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -67.65 -36.3 87.56 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.338 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -85.76 -40.38 16.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.981 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.99 -35.49 80.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.25 -45.08 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 -43.96 98.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.68 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -44.52 97.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.2 m -71.51 -28.84 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -75.97 -20.21 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.559 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.82 -25.73 4.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -96.06 -10.56 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.613 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m120 66.29 33.3 7.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.042 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -163.8 30.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.74 114.3 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.117 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 50' ' ' ARG . 9.1 t -98.42 140.2 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 114.21 3.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.619 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -121.33 130.45 53.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.06 96.44 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.84 132.52 38.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.28 118.16 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -104.2 -81.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.26 43.44 2.93 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.86 47.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.299 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -122.71 89.41 50.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.45 153.09 70.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -160.03 171.68 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.1 m -126.22 108.83 11.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.798 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 m -98.75 148.97 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -116.37 100.88 8.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.761 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.23 106.16 3.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 0.6 OUTLIER -160.69 42.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.781 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -96.62 75.02 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.73 -102.91 2.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -144.21 94.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.78 157.14 6.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -108.19 168.89 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.47 135.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -113.64 -50.42 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.53 43.34 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.059 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.1 -29.61 8.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.853 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.86 11.65 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.279 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.2 9.59 7.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.48 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m 38.85 90.72 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.52 -15.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.366 2.044 . . . . 0.0 112.404 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.37 -11.67 6.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.72 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 -29.95 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.828 0.347 . . . . 0.0 111.056 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.2 p -53.21 -28.84 28.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.139 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -43.12 62.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.76 -31.12 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.43 70.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -91.47 -22.37 20.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.06 -30.83 64.86 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.575 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.58 -42.91 13.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.306 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.31 -45.4 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -61.74 -51.46 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 111.098 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 p -58.34 -49.97 75.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 m -70.9 -14.91 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -86.13 -23.66 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.28 -28.51 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.29 -17.14 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.355 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.76 26.64 13.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -154.98 26.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.6 110.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.921 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.411 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 9.9 t -95.86 128.22 42.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.03 125.5 6.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.757 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.8 133.96 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.613 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.19 92.41 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.058 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.7 115.58 22.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.3 115.13 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -81.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.715 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.21 39.73 3.08 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.278 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.01 31.87 33.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -132.07 89.2 38.71 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.64 148.7 90.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.592 2.195 . . . . 0.0 112.134 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -142.16 137.77 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.89 78.5 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.93 133.61 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 39.0 m -124.24 107.43 11.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.25 116.47 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.423 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 8.9 ttt85 -160.5 34.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.86 80.59 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.24 -31.08 2.3 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.425 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.908 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.8 0.333 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.37 90.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -168.94 55.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -107.3 147.33 30.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.25 155.71 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 31.22 6.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -119.38 36.05 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.767 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.3 49.59 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.42 -54.4 1.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 ttm 59.98 30.58 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -87.29 -26.61 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 m -54.1 161.07 2.0 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.62 -25.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.609 2.206 . . . . 0.0 112.468 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.02 31.04 0.97 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.756 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.71 -0.98 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.487 0.184 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -64.58 -30.76 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -44.77 80.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -76.39 -33.02 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.57 -23.67 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.91 -25.17 18.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.67 64.56 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.408 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.35 -39.88 18.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.115 -0.543 . . . . 0.0 110.214 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.61 -39.93 95.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.324 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.5 tp -70.16 -47.92 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.357 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 m -64.72 -56.16 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.306 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -31.62 63.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -90.43 -12.12 38.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -83.14 -27.67 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.599 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.06 -29.03 69.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.99 -7.4 53.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.501 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 m120 50.92 32.46 7.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 111.565 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -166.3 31.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 114.71 0.62 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.144 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 50' ' ' ARG . 10.6 t -102.49 128.95 48.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.62 126.63 7.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.769 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.1 129.8 42.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.335 . . . . 0.0 110.602 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.23 92.44 8.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -84.02 157.64 21.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -158.81 116.08 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -106.79 -82.97 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.33 32.8 4.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.244 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.18 30.78 13.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.092 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 116.11 30.02 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.607 0.241 . . . . 0.0 110.949 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 105.61 2.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.487 2.124 . . . . 0.0 112.299 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -93.73 141.67 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 82.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.1 m -81.53 161.52 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.7 m -155.77 106.73 2.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.21 120.36 2.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.44 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 ttt-85 -160.61 40.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.733 0.302 . . . . 0.0 111.252 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -96.31 101.78 13.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.45 85.4 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -124.84 21.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 p30 178.19 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 114.66 10.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.956 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 m -118.17 45.28 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 m -154.4 30.67 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.4 p -51.82 -59.96 3.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.284 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 54.82 21.64 3.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.479 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.52 6.89 5.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.78 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.2 tpt 46.5 29.14 0.85 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.72 0.295 . . . . 0.0 111.352 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -177.89 60.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 16' ' ' SER . 27.0 m -64.92 112.55 8.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.298 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 16' ' ' SER . 86.7 Cg_endo -84.59 -29.81 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.628 2.218 . . . . 0.0 112.493 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.83 -36.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.333 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.74 32.1 1.82 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.009 0.405 . . . . 0.0 111.905 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.452 ' HB3' ' HA ' ' A' ' 12' ' ' VAL . 47.2 t -81.35 -32.97 32.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.663 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -43.31 84.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.91 -31.5 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.47 70.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -91.76 -24.16 19.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.04 -31.13 64.54 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.482 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.69 -40.69 15.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.37 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -36.15 82.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.359 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.52 -47.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.628 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -65.79 -46.64 77.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.155 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -59.38 -47.0 87.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.356 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.1 -14.47 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.529 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -82.31 -25.24 34.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.96 -29.72 43.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.268 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -13.88 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.441 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m120 58.87 25.1 13.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -148.56 21.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 110.88 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.055 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.425 HG22 ' CD2' ' A' ' 36' ' ' HIS . 11.8 t -97.79 126.87 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.653 0.263 . . . . 0.0 110.367 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 130.95 10.18 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.609 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.425 ' CD2' HG22 ' A' ' 34' ' ' THR . 57.2 m-70 -141.41 152.57 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.9 m -79.95 88.52 5.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.004 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.86 94.65 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 131.85 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -77.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.22 25.45 12.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 32.77 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.322 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 81.91 14.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.702 0.287 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.22 107.29 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.616 2.211 . . . . 0.0 112.094 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 m -120.32 155.92 32.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 88.9 2.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.97 125.57 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.2 m -117.62 107.23 13.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -154.05 116.03 4.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 35.4 ttt180 -160.16 28.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.88 54.84 3.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.19 35.33 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.549 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.815 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.04 -47.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -162.43 -178.67 6.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.41 34.85 3.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 t 60.05 88.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -66.53 0.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -126.19 66.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.64 31.15 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.58 -56.65 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.1 ttt 60.24 31.11 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -130.48 35.79 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -79.7 154.25 75.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.62 -37.99 95.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.658 2.239 . . . . 0.0 112.347 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' N ' HD11 ' A' ' 15' ' ' LEU . . . 137.15 37.84 0.16 Allowed Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.023 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -146.15 -21.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.4 t -56.18 -23.85 37.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.651 0.263 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -67.22 -48.04 69.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.93 -32.78 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -25.11 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -92.86 -24.71 18.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.84 -34.48 62.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.443 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.81 -40.24 17.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.356 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.9 -35.7 81.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.44 -46.93 36.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.545 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -51.1 60.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.338 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 t -60.0 -39.8 87.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.9 m -82.24 -16.44 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -80.14 -27.65 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.642 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.61 -27.61 67.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.299 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.18 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.556 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.19 31.91 2.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.839 0.352 . . . . 0.0 111.667 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.73 29.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.82 114.24 0.6 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.009 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.422 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 12.7 t -104.28 123.84 48.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.909 0.354 . . . . 0.0 110.397 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 103.33 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -112.73 142.83 44.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.326 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.6 p -81.48 86.41 6.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -167.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -159.58 120.88 3.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -98.71 -86.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 28.12 7.8 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.381 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.58 8.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.107 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.93 139.88 20.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.642 0.258 . . . . 0.0 111.012 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.74 144.59 42.73 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.568 2.179 . . . . 0.0 112.408 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -133.19 141.52 48.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.776 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.12 74.17 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.88 125.98 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.5 m -119.75 108.14 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 111.374 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -160.0 119.7 2.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.602 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.8 ttt85 -160.56 39.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.69 54.61 1.33 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.03 81.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.415 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 1' ' ' ALA . 7.6 p 43.79 60.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.636 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 71.71 57.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.256 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 21.4 m-85 -147.62 -47.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.787 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 t -142.03 169.98 16.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.782 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.52 -82.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m 49.36 67.23 0.92 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.03 41.27 1.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -108.63 -40.3 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtp 59.26 50.51 7.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.3 33.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -117.54 115.0 37.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.45 -52.5 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.436 2.09 . . . . 0.0 112.388 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.66 36.46 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.572 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.12 -16.52 15.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 111.251 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -20.69 41.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -79.34 -49.29 12.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.033 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.55 -38.4 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.078 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -92.4 -21.99 19.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.08 -33.5 59.39 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.49 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.91 -42.35 15.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.093 -0.553 . . . . 0.0 110.375 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -37.04 82.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -73.76 -49.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.229 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -62.3 -52.13 64.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.3 p -53.87 -44.55 70.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.55 -8.28 59.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.56 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -85.1 -26.63 26.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -50.4 -26.61 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.483 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -86.23 -17.34 35.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.61 33.6 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 m -161.0 29.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.6 113.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.005 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.43 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.0 t -101.51 129.95 47.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 135.76 15.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.544 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 148.49 25.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.05 97.31 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -110.27 145.97 36.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 148.39 51.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.3 -81.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.33 48.68 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.897 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.37 31.04 76.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.976 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.91 124.84 14.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.491 0.186 . . . . 0.0 111.136 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.04 154.11 34.96 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.426 2.084 . . . . 0.0 112.223 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.8 m -158.04 155.4 29.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.16 91.56 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.9 136.22 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -128.56 106.86 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.69 119.04 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.795 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt85 -160.42 35.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.331 . . . . 0.0 111.064 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -90.04 78.11 6.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.48 -166.63 53.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.0 mtt-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 t -117.01 157.57 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.39 154.45 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.76 -37.75 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -80.93 -178.02 6.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.9 p -104.46 -22.72 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.27 73.26 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.29 25.03 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.42 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.09 -33.61 12.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.96 30.52 20.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.957 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -108.41 30.63 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.55 158.73 33.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -50.15 -26.03 14.23 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.693 2.262 . . . . 0.0 112.513 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.76 81.82 0.77 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.268 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.74 -27.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.608 0.242 . . . . 0.0 111.337 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -42.25 -31.31 0.38 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.635 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -53.48 37.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.76 -43.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.726 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.74 -22.16 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.059 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -90.79 -25.74 19.8 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.97 -33.82 70.45 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.504 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.01 -38.07 21.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.394 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -38.16 86.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.429 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 7.3 tp -70.97 -49.44 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.49 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -67.63 -49.7 61.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.796 0.332 . . . . 0.0 111.053 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.2 t -53.08 -41.46 64.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.223 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m -87.01 -10.36 53.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.3 mtpt -79.81 -26.5 40.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 0.0 110.975 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -38.16 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.41 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -72.27 -14.59 61.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 t30 59.24 27.49 16.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 22.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.11 114.23 0.6 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.144 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.8 t -101.44 129.16 47.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.73 120.68 5.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.669 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.4 139.5 53.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 110.679 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 p -90.42 88.46 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.66 143.54 27.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.745 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -143.66 128.07 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -110.57 -82.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.28 35.5 3.8 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.55 22.24 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.167 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -131.27 116.01 16.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.192 . . . . 0.0 110.996 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.31 156.7 50.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.388 2.059 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.4 m -147.5 148.72 31.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.5 t -105.93 79.94 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.962 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.7 m -79.93 129.14 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.686 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m -117.57 106.53 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.019 0.438 . . . . 0.0 111.501 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.25 115.49 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.239 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -160.58 53.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 111.232 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.4 m -87.2 56.0 3.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.06 118.88 3.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.615 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.803 0.335 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.09 114.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 60.61 86.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -85.81 -30.44 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 t -97.06 39.62 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -138.47 62.72 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.9 m 60.82 47.53 7.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.14 30.23 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -49.02 9.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.96 29.45 18.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.09 -24.61 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.988 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.2 154.97 7.28 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -51.12 -24.77 15.39 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.779 2.319 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.62 47.77 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.084 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -158.41 27.77 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.712 0.292 . . . . 0.0 111.064 179.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -28.61 67.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -63.51 -48.24 78.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.07 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.42 -29.56 68.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -91.41 -22.19 20.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.39 62.51 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.554 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.1 -42.65 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.18 -0.51 . . . . 0.0 110.432 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -41.24 97.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.32 -47.39 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.455 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.5 t -62.97 -53.89 46.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -53.24 -37.14 61.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 1.2 m -82.61 -17.53 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.305 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -22.98 42.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -31.23 16.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.517 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -85.51 -18.61 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.685 0.279 . . . . 0.0 111.486 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 t30 66.42 29.53 9.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.893 0.378 . . . . 0.0 110.962 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.61 29.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.62 122.17 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.542 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.444 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 14.9 t -110.68 135.19 51.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 110.245 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.6 108.81 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.685 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -115.65 139.94 49.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 0.0 110.663 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.02 89.49 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.55 168.04 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -145.28 109.84 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -86.17 -85.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.773 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.3 24.66 15.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.384 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.22 29.85 6.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.059 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -127.55 117.7 21.31 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.98 94.18 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.469 2.113 . . . . 0.0 112.183 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.5 m -99.62 155.06 17.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.3 t -108.12 100.46 9.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.7 m -79.95 143.12 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t -118.18 99.06 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.132 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -160.16 119.61 2.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.739 0.304 . . . . 0.0 111.675 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 7.2 ttt85 -160.6 28.73 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.8 52.79 2.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.952 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.63 -142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.536 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.826 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.786 0.327 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.22 115.97 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.18 164.61 27.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.98 41.28 14.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -137.79 114.31 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.06 -74.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.42 -35.89 82.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 -31.14 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -78.51 -24.59 45.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.2 mtp 65.27 30.06 11.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.764 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.16 38.93 4.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -105.88 92.76 6.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.59 58.06 5.75 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.727 2.284 . . . . 0.0 112.669 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.44 -58.47 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -159.33 25.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.676 0.274 . . . . 0.0 111.131 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -89.02 -25.06 22.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.09 -41.72 49.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.059 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.21 -32.96 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.88 -30.35 61.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -92.82 -22.83 19.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.27 -34.34 64.2 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.58 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -85.32 -41.74 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.236 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 1.3 m -62.74 -36.24 82.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.419 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 tp -75.39 -44.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.178 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.0 p -59.67 -56.86 16.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.81 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t -55.91 -42.19 75.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 m -70.23 -22.02 62.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -77.82 -26.89 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.94 -33.73 64.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 15.7 pt20 -87.0 -20.12 27.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 76.32 -41.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.74 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.31 36.5 0.79 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.655 0.264 . . . . 0.0 111.15 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.79 122.57 1.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.085 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 50' ' ' ARG . 6.7 t -103.25 130.06 50.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.91 111.76 4.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -132.17 159.32 39.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.1 t -95.26 93.39 7.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -173.91 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.41 132.79 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -108.35 -85.2 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.34 43.72 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.276 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.22 29.47 56.4 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.982 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.87 148.88 71.21 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.716 0.293 . . . . 0.0 110.992 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 133.99 22.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.605 2.203 . . . . 0.0 112.406 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 m -138.21 157.19 46.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.65 98.44 6.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 145.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 t -131.33 97.88 4.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.97 121.77 3.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.602 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 24.4 ttp180 -160.03 28.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 t -88.37 125.63 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.47 169.17 6.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.927 -179.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 m -98.1 30.92 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -157.58 143.36 17.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -106.35 139.32 41.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.7 m -88.55 -54.63 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 p -170.61 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 38.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.09 -57.4 12.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' O ' ' CB ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -73.18 -49.24 29.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER 83.33 -50.14 0.15 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 p30 43.46 33.16 0.59 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.115 0.483 . . . . 0.0 110.623 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.96 137.13 30.13 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.192 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.7 -61.01 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.697 2.264 . . . . 0.0 112.527 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.89 36.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.92 -21.4 12.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -53.29 -25.04 13.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.189 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -43.88 65.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 t -83.15 -34.09 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -26.23 66.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -31.92 14.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.81 -32.76 83.85 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.586 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -84.99 -41.6 15.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.361 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.1 -34.82 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.0 tp -75.49 -46.74 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.475 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.8 m -66.97 -48.0 69.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.232 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -60.64 -42.34 96.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.585 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m -82.47 -14.71 54.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.759 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -26.86 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -24.61 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.427 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -17.21 34.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.437 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.0 30.33 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -157.61 27.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 113.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.027 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.441 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 11.7 t -97.86 128.66 44.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 129.55 9.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.825 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -141.48 118.35 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.634 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.7 p -80.0 94.35 5.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 171.4 9.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.57 131.55 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -87.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.46 25.99 11.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.376 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 28.27 7.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 124.67 26.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.516 0.198 . . . . 0.0 111.048 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.56 86.73 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 m -80.06 145.25 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 89.89 3.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -80.01 162.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 34' ' ' THR . 80.2 m -152.52 109.11 3.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -160.0 119.06 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.441 ' HB2' ' N ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -160.54 35.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -92.66 52.56 1.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 161.65 13.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.934 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 7.4 p -122.48 -44.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.081 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 1.7 t0 81.85 -13.17 0.9 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.825 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 3' ' ' ASP . 50.3 m-85 -146.68 83.71 1.6 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.3 -66.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m 61.34 76.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.26 44.67 1.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.743 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.21 24.97 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.223 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.82 -51.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 59.9 36.33 21.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.34 40.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.979 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.01 147.02 95.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 18.2 Cg_endo -60.8 -37.96 74.19 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' HD12 ' A' ' 15' ' ' LEU . . . 145.27 45.1 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.33 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.53 -34.92 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.793 0.297 . . . . 0.0 111.157 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.5 t -56.13 -23.82 36.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.349 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -65.92 -40.94 91.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -83.9 -34.06 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.88 -36.35 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -90.75 -21.03 21.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.5 -34.33 78.95 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.425 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -85.34 -42.2 14.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -34.17 76.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.18 -46.99 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.021 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.2 m -63.45 -48.81 76.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -57.4 -49.66 75.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.349 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.77 -13.33 60.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.83 -26.62 34.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -36.05 25.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -72.97 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.353 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 64.59 26.62 13.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -153.73 23.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.49 113.38 0.56 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.935 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.432 ' N ' ' HB2' ' A' ' 50' ' ' ARG . 13.9 t -103.16 134.56 46.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.74 0.305 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.84 130.8 10.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.709 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.45 150.95 45.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.92 90.88 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.54 88.55 5.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 -178.46 5.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.56 -75.9 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.73 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 15.82 58.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.654 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 29.23 2.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -114.39 85.79 11.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.19 92.24 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.532 2.154 . . . . 0.0 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -98.76 144.57 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.68 94.02 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -83.11 126.06 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 83.9 m -116.8 104.5 11.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.02 116.0 4.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.634 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.8 ttp85 -160.41 28.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.051 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.51 161.09 17.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.842 0.353 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.64 -131.94 1.67 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.915 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.794 0.33 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.91 133.95 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.79 82.33 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 t80 60.21 99.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.75 98.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -34.09 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 m -91.6 -34.07 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.992 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.82 35.87 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -158.47 -42.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.6 mmm -51.09 -26.04 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.368 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 66.38 44.93 2.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.777 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.48 85.0 38.68 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.052 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.71 57.86 5.76 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 0.0 112.493 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -43.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.64 3.73 23.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.8 p -59.48 -31.39 69.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -83.04 -52.83 6.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.991 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.92 -37.11 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.95 69.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.233 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -23.33 19.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.51 -33.38 61.1 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.544 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.15 -42.74 15.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -41.23 96.3 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.367 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 tp -70.22 -47.86 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.69 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 p -63.65 -55.61 22.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 0.0 111.057 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -52.37 -37.97 57.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 3.7 m -80.44 -22.26 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.314 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.8 tptt -73.05 -26.06 61.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -56.25 -22.34 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.686 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -92.61 -9.87 39.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.56 30.07 16.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.197 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 31.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.34 125.52 1.45 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.837 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.495 ' HB ' ' HG3' ' A' ' 50' ' ' ARG . 9.9 t -116.87 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.687 0.28 . . . . 0.0 110.25 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.44 110.16 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.657 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -119.12 126.45 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 0.0 110.708 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.5 p -80.0 93.7 5.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.87 151.68 19.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.785 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 137.09 9.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.954 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -128.69 -82.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.06 46.95 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.9 31.59 59.88 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -126.69 89.05 53.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.15 124.39 9.5 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.629 2.22 . . . . 0.0 112.325 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.0 m -130.47 162.36 29.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 100.55 7.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.86 140.18 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.08 93.66 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' O ' ' CG2' ' A' ' 34' ' ' THR . 3.1 m-20 -160.35 121.8 3.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HG3' ' HB ' ' A' ' 34' ' ' THR . 3.7 tmm_? -161.1 60.9 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 m -92.39 149.13 21.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.18 -45.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.504 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.877 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.03 -31.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.38 66.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 16.1 pt20 -91.76 -25.53 19.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.48 -34.05 88.1 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.404 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.74 -41.37 15.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.279 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.585 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.77 -34.15 75.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.592 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.686 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.62 -46.88 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.189 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.5 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -63.85 -47.66 79.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.069 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.4 p -60.33 -48.96 79.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 m -73.22 -17.14 61.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.457 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -83.17 -23.03 33.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.92 -31.55 17.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -78.45 -15.26 58.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 m120 67.11 28.15 8.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.0 25.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.63 109.62 0.4 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.057 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -97.39 130.41 44.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.89 125.13 6.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.632 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -131.37 133.45 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.775 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.26 92.35 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -89.11 89.97 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 147.74 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -135.21 -80.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.958 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 23.78 19.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.749 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.7 24.53 7.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.405 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 87.89 25.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 109.07 2.39 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.567 2.178 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -107.17 147.91 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.5 t -109.44 87.97 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.22 133.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -121.89 111.74 17.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 34' ' ' THR . 17.2 p-10 -159.99 115.62 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 tpt180 -160.62 37.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.976 0.417 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.72 -33.54 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.725 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.68 -25.87 68.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 24' ' ' ILE . 27.9 tp60 -92.26 -25.96 18.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -31.73 65.68 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.566 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.88 -39.82 16.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.49 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -63.95 -34.96 79.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.2 tp -77.03 -46.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.515 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 37.5 t -66.45 -47.63 72.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.216 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -61.43 -45.54 93.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.285 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.53 -17.84 59.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.508 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -23.34 34.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 111.061 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.75 -39.12 67.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.23 -15.51 62.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 64.56 29.41 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.99 25.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 112.09 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.072 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -101.5 123.03 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.278 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.79 132.18 11.17 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.76 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.3 142.4 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.745 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.4 p -79.98 88.85 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.55 168.92 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.96 132.48 18.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.32 -85.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 40.28 3.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.407 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.77 29.13 39.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.086 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.84 142.66 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.248 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.66 157.46 60.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.422 2.081 . . . . 0.0 112.414 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -151.5 139.15 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.62 83.38 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.94 117.11 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 78.9 m -113.22 106.12 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.7 OUTLIER -155.98 117.95 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.546 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' N ' ' A' ' 34' ' ' THR . 52.7 ttt-85 -160.5 35.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.939 0.4 . . . . 0.0 110.937 -179.956 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tptt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.837 0.351 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 t -71.36 -29.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.14 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.71 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.602 ' O ' HG22 ' A' ' 24' ' ' ILE . 5.4 pt20 -90.59 -20.47 22.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.11 -34.58 58.24 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.701 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.79 -39.52 18.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.557 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.4 -39.45 94.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.97 0.414 . . . . 0.0 110.293 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.1 tp -71.49 -49.34 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.499 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.541 ' N ' HG23 ' A' ' 24' ' ' ILE . 89.1 p -63.04 -50.19 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -56.0 -38.25 70.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.1 m -84.68 -10.23 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -85.58 -26.18 26.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -29.45 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -83.11 -16.83 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.356 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.66 28.51 17.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.725 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -152.71 25.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.52 110.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.997 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -100.8 124.41 46.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.376 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.97 133.37 12.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.627 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 143.35 30.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.91 97.05 6.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -96.16 130.77 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 127.05 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -118.41 -81.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.08 3.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.29 31.85 68.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.089 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 108.65 7.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.532 0.206 . . . . 0.0 111.156 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.14 148.4 39.43 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.44 2.093 . . . . 0.0 112.388 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -141.25 175.7 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.1 t -116.91 85.9 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.85 121.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.3 m -114.33 109.33 18.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.884 ' O ' HG22 ' A' ' 34' ' ' THR . 7.3 m-20 -158.92 118.21 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.394 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HB2' ' N ' ' A' ' 34' ' ' THR . 6.6 ttt-85 -160.53 34.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.5 t -64.88 -42.15 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.1 -22.83 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tp-100 -91.51 -23.85 19.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.45 -33.0 59.14 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.57 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -84.63 -38.82 19.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -65.63 -37.33 86.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.392 . . . . 0.0 110.506 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -72.97 -49.39 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.558 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -66.54 -49.39 66.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 0.0 111.15 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -54.85 -43.64 73.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.2 m -86.56 -6.32 58.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.526 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtpt -84.47 -26.5 28.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -38.76 57.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -69.28 -18.74 63.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.353 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 65.14 30.87 11.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.759 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.48 29.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 114.63 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.007 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.9 t -102.66 128.67 49.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 132.56 11.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -141.39 124.73 16.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.638 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.9 p -79.93 93.71 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.27 174.55 5.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 126.39 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.28 -85.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.923 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 40.94 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.207 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.01 30.41 42.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.928 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 95.49 37.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.644 0.259 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 120.74 8.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.465 2.11 . . . . 0.0 112.144 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 m -124.91 158.09 34.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.73 94.58 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -79.98 130.68 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.0 m -121.0 103.87 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 5.4 m-20 -156.95 119.21 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -160.6 36.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.191 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.743 0.306 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 t -60.52 -38.87 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.73 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.054 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.622 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.3 tm0? -91.73 -24.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.32 -34.74 75.21 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.569 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -84.62 -41.59 16.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.219 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.558 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -63.73 -36.03 82.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.3 tp -74.28 -46.13 45.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.326 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.0 t -66.04 -51.52 57.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -57.29 -40.3 77.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.279 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.67 -10.61 57.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.667 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -83.56 -27.63 29.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 110.708 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.17 -26.69 29.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.01 -14.72 40.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.49 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 58.36 26.05 13.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.58 21.84 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.55 109.37 0.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.957 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -98.28 123.24 42.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.413 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 111.72 3.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.578 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -118.65 150.08 40.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.5 p -83.92 83.59 7.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.607 ' HG3' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -82.33 -176.08 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.98 139.87 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -118.47 -86.77 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.36 29.58 6.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.402 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.06 27.94 10.45 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.116 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.72 147.35 59.08 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.659 0.266 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 147.3 82.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.164 . . . . 0.0 112.392 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -138.19 151.51 47.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.805 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -105.88 79.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 38' ' ' GLU . 7.3 m -80.84 121.81 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.7 m -113.68 108.85 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -158.2 116.96 3.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.583 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 32.7 ttt85 -160.47 33.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.984 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 110.948 -179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.905 0.384 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.14 -41.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.33 -24.22 66.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.587 ' O ' HG22 ' A' ' 24' ' ' ILE . 55.5 tt0 -92.71 -23.18 19.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.82 -33.4 60.2 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.581 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.6 pp -85.68 -41.35 15.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.314 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -62.13 -35.85 79.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.47 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.635 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.76 -47.2 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 24' ' ' ILE . 3.9 p -62.65 -52.76 62.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 p -55.84 -47.0 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.394 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.5 m -78.07 -8.12 57.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.716 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -87.75 -25.42 23.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.672 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -50.84 -26.7 6.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.12 -14.38 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.379 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 63.5 32.31 14.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.807 0.337 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -160.76 28.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.61 112.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.033 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -101.22 135.0 43.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 132.16 11.15 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.764 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -141.64 140.19 33.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.1 p -79.91 89.68 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.982 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.63 106.94 19.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.61 160.02 26.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -142.99 -80.29 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.27 39.31 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.613 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.24 26.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.65 98.92 27.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 111.033 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 91.95 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.475 2.117 . . . . 0.0 112.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -86.42 145.43 26.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.09 90.99 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -79.98 140.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.33 110.09 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 8.5 p-10 -160.14 117.55 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.438 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.4 ttt85 -160.27 33.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.204 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.876 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.41 -33.89 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.13 69.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.196 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.2 pt20 -91.66 -24.45 19.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.53 -31.78 71.08 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.603 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -86.28 -44.7 11.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.269 -0.466 . . . . 0.0 110.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.43 -34.8 72.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.608 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.724 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.11 -45.32 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.227 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 53.3 p -62.41 -49.81 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.3 m -63.21 -47.48 82.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.367 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.16 -20.78 64.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -87.39 -19.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.693 0.283 . . . . 0.0 111.222 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.256 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -80.19 -12.49 59.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.92 32.5 13.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.867 0.365 . . . . 0.0 110.823 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -159.72 28.11 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.5 112.1 0.51 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.993 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -96.81 129.84 44.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.96 138.81 20.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.69 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -154.82 150.38 27.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.688 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 p -92.98 78.19 4.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 -170.07 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 142.46 23.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -81.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.29 35.17 3.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.412 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 29.68 23.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.122 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -148.18 147.17 25.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.291 . . . . 0.0 111.06 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.99 162.39 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.619 2.213 . . . . 0.0 112.328 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -154.42 143.44 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.9 79.78 4.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' HIS . 27.2 m -79.96 136.23 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.4 m -133.6 108.34 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -160.01 117.12 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.7 OUTLIER -160.64 39.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.041 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.914 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tptt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -31.14 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.019 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -68.48 -27.35 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.045 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -90.66 -23.46 20.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -32.58 62.6 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.526 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -83.72 -42.01 17.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.325 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.601 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -64.76 -37.78 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.531 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.3 tp -71.06 -47.62 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.527 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.9 t -67.13 -50.85 59.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -52.62 -42.29 64.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -84.81 -13.27 51.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.322 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.23 -25.46 51.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.735 0.303 . . . . 0.0 110.785 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -39.62 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.32 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.0 -18.23 60.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.276 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.07 31.95 10.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 m -159.26 26.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.082 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.64 109.69 0.41 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.35 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.0 t -97.68 126.28 42.93 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 135.08 14.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.805 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -149.33 135.99 19.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 45' ' ' THR . 19.7 p -79.95 102.67 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -105.47 133.33 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -120.65 112.71 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -97.12 -81.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.731 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 22.33 27.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.316 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.93 5.47 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.055 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -132.27 109.31 13.75 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.595 0.236 . . . . 0.0 111.055 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 87.82 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' CYS . 10.5 t -86.8 164.72 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 89.09 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.95 134.95 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.3 m -121.04 113.1 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.994 0.426 . . . . 0.0 111.384 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 1.6 m-20 -159.77 116.14 2.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.638 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 2.2 tpt180 -160.68 39.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.08 -32.67 33.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.43 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.978 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.6 pt20 -93.41 -24.71 17.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.65 -36.3 87.56 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.338 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -85.76 -40.38 16.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.981 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 22' ' ' LEU . 3.4 m -62.99 -35.49 80.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.733 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.25 -45.08 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 24' ' ' ILE . 93.6 p -61.23 -43.96 98.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.68 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -44.52 97.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.2 m -71.51 -28.84 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -75.97 -20.21 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.559 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.82 -25.73 4.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -96.06 -10.56 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.613 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m120 66.29 33.3 7.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.042 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -163.8 30.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.74 114.3 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.117 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.1 t -98.42 140.2 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 114.21 3.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.619 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -121.33 130.45 53.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.06 96.44 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 45' ' ' THR . 4.9 mm-40 -93.84 132.52 38.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.28 118.16 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -104.2 -81.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.26 43.44 2.93 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.86 47.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.299 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -122.71 89.41 50.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.45 153.09 70.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' GLU . 12.4 t -160.03 171.68 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.1 m -126.22 108.83 11.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.798 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 m -98.75 148.97 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -116.37 100.88 8.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.761 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.908 ' O ' HG22 ' A' ' 34' ' ' THR . 1.0 OUTLIER -148.23 106.16 3.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -160.69 42.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.781 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 -179.848 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.76 -31.12 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.43 70.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.591 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.5 pt20 -91.47 -22.37 20.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.06 -30.83 64.86 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.575 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -86.58 -42.91 13.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.306 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.632 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.701 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.31 -45.4 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.2 m -61.74 -51.46 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 111.098 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 p -58.34 -49.97 75.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 m -70.9 -14.91 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 24' ' ' ILE . 2.4 tppt? -86.13 -23.66 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.28 -28.51 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.29 -17.14 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.355 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.76 26.64 13.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -154.98 26.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.6 110.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.921 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.896 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -95.86 128.22 42.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.03 125.5 6.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.757 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.8 133.96 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.613 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.19 92.41 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.058 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.7 115.58 22.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.3 115.13 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -81.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.715 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.21 39.73 3.08 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.278 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.01 31.87 33.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -132.07 89.2 38.71 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.64 148.7 90.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.592 2.195 . . . . 0.0 112.134 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -142.16 137.77 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.89 78.5 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.93 133.61 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 39.0 m -124.24 107.43 11.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -157.25 116.47 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 8.9 ttt85 -160.5 34.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -76.39 -33.02 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.57 -23.67 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -92.91 -25.17 18.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.67 64.56 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.408 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -84.35 -39.88 18.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.115 -0.543 . . . . 0.0 110.214 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.593 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -63.61 -39.93 95.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.324 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.5 tp -70.16 -47.92 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.357 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 24' ' ' ILE . 7.8 m -64.72 -56.16 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.306 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -31.62 63.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -90.43 -12.12 38.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -83.14 -27.67 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.599 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.06 -29.03 69.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.487 ' NE2' ' HA3' ' A' ' 33' ' ' GLY . 5.2 pt20 -74.99 -7.4 53.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.501 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 m120 50.92 32.46 7.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 111.565 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -166.3 31.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA3' ' NE2' ' A' ' 30' ' ' GLN . . . -160.57 114.71 0.62 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.144 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.6 t -102.49 128.95 48.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.62 126.63 7.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -131.1 129.8 42.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.335 . . . . 0.0 110.602 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.23 92.44 8.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -84.02 157.64 21.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -158.81 116.08 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -106.79 -82.97 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.33 32.8 4.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.244 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.18 30.78 13.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.092 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 116.11 30.02 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.607 0.241 . . . . 0.0 110.949 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 105.61 2.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.487 2.124 . . . . 0.0 112.299 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -93.73 141.67 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 82.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 36' ' ' HIS . 31.1 m -81.53 161.52 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.7 m -155.77 106.73 2.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 11.6 t70 -160.21 120.36 2.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 3.4 ttt-85 -160.61 40.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.733 0.302 . . . . 0.0 111.252 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.867 0.365 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.91 -31.5 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.07 -30.47 70.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.614 ' O ' HG22 ' A' ' 24' ' ' ILE . 10.8 pt20 -91.76 -24.16 19.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.04 -31.13 64.54 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.482 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.69 -40.69 15.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.37 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.47 -36.15 82.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.359 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.8 tp -75.52 -47.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.628 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' HG23 ' A' ' 24' ' ' ILE . 30.3 t -65.79 -46.64 77.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.155 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -59.38 -47.0 87.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.356 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.1 -14.47 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.529 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -82.31 -25.24 34.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.96 -29.72 43.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.268 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -81.6 -13.88 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.441 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m120 58.87 25.1 13.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -148.56 21.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 110.88 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.055 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.8 t -97.79 126.87 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.653 0.263 . . . . 0.0 110.367 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.81 130.95 10.18 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.609 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -141.41 152.57 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.9 m -79.95 88.52 5.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.004 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.86 94.65 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 131.85 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -77.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.22 25.45 12.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 32.77 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.322 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 81.91 14.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.702 0.287 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.22 107.29 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.616 2.211 . . . . 0.0 112.094 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 m -120.32 155.92 32.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 88.9 2.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.97 125.57 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.2 m -117.62 107.23 13.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.904 ' O ' HG22 ' A' ' 34' ' ' THR . 14.1 p-10 -154.05 116.03 4.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 35.4 ttt180 -160.16 28.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.878 0.37 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.93 -32.78 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -25.11 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.0 pt20 -92.86 -24.71 18.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.84 -34.48 62.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.443 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -84.81 -40.24 17.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.57 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.6 m -63.9 -35.7 81.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.1 tp -75.44 -46.93 36.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.545 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.3 m -66.49 -51.1 60.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 t -60.0 -39.8 87.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 94.9 m -82.24 -16.44 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -80.14 -27.65 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.642 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.61 -27.61 67.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.299 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 27' ' ' CYS . 4.5 pt20 -79.72 -1.18 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.556 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.19 31.91 2.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.839 0.352 . . . . 0.0 111.667 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.73 29.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.82 114.24 0.6 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.009 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.7 t -104.28 123.84 48.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.909 0.354 . . . . 0.0 110.397 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.8 103.33 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.0 m170 -112.73 142.83 44.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.326 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.6 p -81.48 86.41 6.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -167.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -159.58 120.88 3.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -98.71 -86.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 28.12 7.8 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.381 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.58 8.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.107 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.93 139.88 20.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.642 0.258 . . . . 0.0 111.012 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.74 144.59 42.73 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.568 2.179 . . . . 0.0 112.408 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -133.19 141.52 48.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.776 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.12 74.17 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 36' ' ' HIS . 5.5 m -80.88 125.98 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.5 m -119.75 108.14 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 111.374 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 34' ' ' THR . 12.7 p-10 -160.0 119.7 2.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.602 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.444 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.8 ttt85 -160.56 39.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 -179.885 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tttt . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.807 0.337 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.55 -38.4 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.078 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.56 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.5 tt0 -92.4 -21.99 19.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.08 -33.5 59.39 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.49 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.91 -42.35 15.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.093 -0.553 . . . . 0.0 110.375 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.571 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -61.71 -37.04 82.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -73.76 -49.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.229 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -62.3 -52.13 64.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.3 p -53.87 -44.55 70.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.55 -8.28 59.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.56 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -85.1 -26.63 26.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -50.4 -26.61 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.483 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -86.23 -17.34 35.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.61 33.6 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 m -161.0 29.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.6 113.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.005 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.0 t -101.51 129.95 47.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 135.76 15.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.544 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 148.49 25.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.05 97.31 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -110.27 145.97 36.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 148.39 51.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.3 -81.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.33 48.68 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.897 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.37 31.04 76.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.976 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.91 124.84 14.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.491 0.186 . . . . 0.0 111.136 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.04 154.11 34.96 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.426 2.084 . . . . 0.0 112.223 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.8 m -158.04 155.4 29.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.16 91.56 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.9 136.22 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -128.56 106.86 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 p-10 -157.69 119.04 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.795 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt85 -160.42 35.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.331 . . . . 0.0 111.064 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.872 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.76 -43.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.726 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.74 -22.16 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.651 ' O ' HG22 ' A' ' 24' ' ' ILE . 11.2 tm0? -90.79 -25.74 19.8 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.97 -33.82 70.45 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.504 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.01 -38.07 21.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.394 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.499 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -66.67 -38.16 86.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.429 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -70.97 -49.44 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.49 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.6 m -67.63 -49.7 61.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.796 0.332 . . . . 0.0 111.053 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.2 t -53.08 -41.46 64.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.223 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m -87.01 -10.36 53.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -79.81 -26.5 40.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -38.16 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.41 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -72.27 -14.59 61.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 t30 59.24 27.49 16.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 22.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.11 114.23 0.6 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.144 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.8 t -101.44 129.16 47.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.73 120.68 5.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.669 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.4 139.5 53.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 110.679 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 p -90.42 88.46 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.66 143.54 27.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.745 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -143.66 128.07 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -110.57 -82.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.28 35.5 3.8 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.55 22.24 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.167 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -131.27 116.01 16.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.192 . . . . 0.0 110.996 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.31 156.7 50.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.388 2.059 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.4 m -147.5 148.72 31.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.5 t -105.93 79.94 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.962 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.7 m -79.93 129.14 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.686 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m -117.57 106.53 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.019 0.438 . . . . 0.0 111.501 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -156.25 115.49 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.239 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -160.58 53.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 111.232 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 mttt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.07 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.42 -29.56 68.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.594 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.5 pt20 -91.41 -22.19 20.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.39 62.51 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.554 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.1 -42.65 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.18 -0.51 . . . . 0.0 110.432 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.714 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.78 -41.24 97.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.8 tp -69.32 -47.39 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -62.97 -53.89 46.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -53.24 -37.14 61.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 1.2 m -82.61 -17.53 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.305 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.78 -22.98 42.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -31.23 16.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.517 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -85.51 -18.61 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.685 0.279 . . . . 0.0 111.486 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 t30 66.42 29.53 9.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.893 0.378 . . . . 0.0 110.962 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.61 29.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.62 122.17 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.542 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 14.9 t -110.68 135.19 51.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 110.245 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -85.6 108.81 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.685 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' HB3' HG22 ' A' ' 47' ' ' VAL . 1.6 t60 -115.65 139.94 49.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.02 89.49 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.55 168.04 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -145.28 109.84 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -86.17 -85.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.773 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.3 24.66 15.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.384 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.22 29.85 6.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.059 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -127.55 117.7 21.31 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.98 94.18 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.469 2.113 . . . . 0.0 112.183 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.5 m -99.62 155.06 17.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.3 t -108.12 100.46 9.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 36' ' ' HIS . 29.7 m -79.95 143.12 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.829 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t -118.18 99.06 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.132 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 27.2 t70 -160.16 119.61 2.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.739 0.304 . . . . 0.0 111.675 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.2 ttt85 -160.6 28.73 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.952 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.21 -32.96 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.88 -30.35 61.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tt0 -92.82 -22.83 19.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.27 -34.34 64.2 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.58 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -85.32 -41.74 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.236 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.726 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -62.74 -36.24 82.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.419 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 35' ' ' GLY . 10.7 tp -75.39 -44.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.178 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 87.0 p -59.67 -56.86 16.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.81 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t -55.91 -42.19 75.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 m -70.23 -22.02 62.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -77.82 -26.89 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.94 -33.73 64.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 9.9 pt20 -87.0 -20.12 27.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 76.32 -41.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.74 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.31 36.5 0.79 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.655 0.264 . . . . 0.0 111.15 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 50' ' ' ARG . . . -160.79 122.57 1.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.085 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 49' ' ' ASP . 6.7 t -103.25 130.06 50.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.683 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -92.91 111.76 4.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -132.17 159.32 39.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.1 t -95.26 93.39 7.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -173.91 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.41 132.79 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -108.35 -85.2 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.34 43.72 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.276 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.22 29.47 56.4 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.982 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.87 148.88 71.21 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.716 0.293 . . . . 0.0 110.992 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 133.99 22.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.605 2.203 . . . . 0.0 112.406 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 m -138.21 157.19 46.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.65 98.44 6.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 145.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 t -131.33 97.88 4.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.839 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -159.97 121.77 3.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.602 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.6 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 24.4 ttp180 -160.03 28.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.869 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 t -83.15 -34.09 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.81 -26.23 66.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.643 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -92.6 -31.92 14.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.81 -32.76 83.85 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.586 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.6 pp -84.99 -41.6 15.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.747 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -64.1 -34.82 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.0 tp -75.49 -46.74 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.475 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.501 ' N ' HG23 ' A' ' 24' ' ' ILE . 16.8 m -66.97 -48.0 69.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.232 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -60.64 -42.34 96.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.585 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m -82.47 -14.71 54.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.759 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -81.87 -26.86 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -24.61 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.427 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -86.58 -17.21 34.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.437 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.0 30.33 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -157.61 27.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 113.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.027 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.7 t -97.86 128.66 44.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 129.55 9.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.825 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.9 m80 -141.48 118.35 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.634 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.7 p -80.0 94.35 5.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 171.4 9.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.57 131.55 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -87.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.46 25.99 11.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.376 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 28.27 7.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 124.67 26.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.516 0.198 . . . . 0.0 111.048 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.56 86.73 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 m -80.06 145.25 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 89.89 3.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 36' ' ' HIS . 30.7 m -80.01 162.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.838 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' THR . 80.2 m -152.52 109.11 3.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.892 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 t70 -160.0 119.06 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HB2' ' N ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -160.54 35.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.897 0.38 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.9 t -83.9 -34.06 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.88 -36.35 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.4 tm0? -90.75 -21.03 21.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.5 -34.33 78.95 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.425 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.34 -42.2 14.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.045 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.618 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.7 -34.17 76.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.683 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.18 -46.99 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.021 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 45.2 m -63.45 -48.81 76.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -57.4 -49.66 75.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.349 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.77 -13.33 60.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -81.83 -26.62 34.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -36.05 25.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -72.97 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.353 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 64.59 26.62 13.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -153.73 23.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.49 113.38 0.56 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.935 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 13.9 t -103.16 134.56 46.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.74 0.305 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.84 130.8 10.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.709 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -139.45 150.95 45.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.92 90.88 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -94.54 88.55 5.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 -178.46 5.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.56 -75.9 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.73 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 15.82 58.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.654 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 29.23 2.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -114.39 85.79 11.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.19 92.24 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.532 2.154 . . . . 0.0 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -98.76 144.57 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.68 94.02 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 38' ' ' GLU . 16.8 m -83.11 126.06 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 83.9 m -116.8 104.5 11.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -154.02 116.0 4.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.634 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.455 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.8 ttp85 -160.41 28.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.051 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.842 0.353 . . . . 0.0 110.894 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 mttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.92 -37.11 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -60.4 -30.95 69.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.233 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.577 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -92.04 -23.33 19.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.273 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.51 -33.38 61.1 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.544 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.7 pp -84.15 -42.74 15.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.1 -41.23 96.3 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.367 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.6 tp -70.22 -47.86 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.69 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 24' ' ' ILE . 8.6 p -63.65 -55.61 22.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -52.37 -37.97 57.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 3.7 m -80.44 -22.26 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.314 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.8 tptt -73.05 -26.06 61.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -56.25 -22.34 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.686 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -92.61 -9.87 39.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.56 30.07 16.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.197 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 31.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . -161.34 125.52 1.45 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.837 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -116.87 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.687 0.28 . . . . 0.0 110.25 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.44 110.16 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.657 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -119.12 126.45 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 0.0 110.708 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.5 p -80.0 93.7 5.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.87 151.68 19.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.785 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 137.09 9.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.954 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -128.69 -82.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.06 46.95 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.9 31.59 59.88 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -126.69 89.05 53.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.15 124.39 9.5 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.629 2.22 . . . . 0.0 112.325 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 46' ' ' CYS . 49.0 m -130.47 162.36 29.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.427 ' N ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -118.1 100.55 7.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.86 140.18 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.08 93.66 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.92 ' O ' HG22 ' A' ' 34' ' ' THR . 3.1 m-20 -160.35 121.8 3.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB2' ' N ' ' A' ' 34' ' ' THR . 3.7 tmm_? -161.1 60.9 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 m . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.836 0.351 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 2' ' ' VAL . 19.2 m -135.42 97.59 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -90.31 85.85 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -151.33 -47.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -117.24 158.63 23.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -169.95 83.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.8 50.29 5.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.63 30.59 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 -33.42 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.4 ttm 61.44 30.93 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -94.24 -31.96 13.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.703 HG21 ' CB ' ' A' ' 16' ' ' SER . 6.4 m -69.35 159.69 82.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.153 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.39 -35.76 36.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.697 2.265 . . . . 0.0 112.393 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -15.07 3.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.765 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.21 -19.75 61.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.703 ' CB ' HG21 ' A' ' 12' ' ' VAL . 8.9 t -54.63 -25.54 27.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -44.14 69.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.03 -31.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.38 66.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 16.1 pt20 -91.76 -25.53 19.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.48 -34.05 88.1 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.404 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.74 -41.37 15.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.279 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.585 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.77 -34.15 75.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.592 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.686 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.62 -46.88 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.189 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.5 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -63.85 -47.66 79.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.069 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.4 p -60.33 -48.96 79.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 m -73.22 -17.14 61.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.457 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -83.17 -23.03 33.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.92 -31.55 17.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -78.45 -15.26 58.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 m120 67.11 28.15 8.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.0 25.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.63 109.62 0.4 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.057 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -97.39 130.41 44.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.89 125.13 6.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.632 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -131.37 133.45 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.775 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.26 92.35 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -89.11 89.97 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 147.74 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -135.21 -80.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.958 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 23.78 19.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.749 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.7 24.53 7.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.405 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 87.89 25.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 109.07 2.39 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.567 2.178 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -107.17 147.91 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.5 t -109.44 87.97 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.22 133.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -121.89 111.74 17.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 34' ' ' THR . 17.2 p-10 -159.99 115.62 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 tpt180 -160.62 37.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.28 131.98 39.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.49 117.33 4.26 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 3' ' ' ASP . 28.2 t -70.8 158.97 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 2' ' ' VAL . 36.4 m-20 61.17 166.71 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -100.05 144.15 29.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.7 p -168.71 77.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -120.51 61.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 t -98.83 33.26 2.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.19 -34.35 15.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -137.06 28.27 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -41.79 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.53 35.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.636 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 16' ' ' SER . 21.8 t -78.63 111.87 22.5 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.316 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.6 -25.65 5.32 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.399 2.066 . . . . 0.0 112.117 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 15' ' ' LEU . . . 153.73 44.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.372 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER 173.28 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 111.209 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.691 ' HB3' HG22 ' A' ' 12' ' ' VAL . 4.5 t -46.66 -28.99 1.65 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.38 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -45.44 92.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.976 0.417 . . . . 0.0 110.568 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.72 -33.54 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.725 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.68 -25.87 68.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 24' ' ' ILE . 27.9 tp60 -92.26 -25.96 18.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -31.73 65.68 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.566 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.88 -39.82 16.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.49 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -63.95 -34.96 79.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.2 tp -77.03 -46.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.515 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 37.5 t -66.45 -47.63 72.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.216 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -61.43 -45.54 93.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.285 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.53 -17.84 59.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.508 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -23.34 34.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 111.061 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.75 -39.12 67.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.23 -15.51 62.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 64.56 29.41 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.99 25.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 112.09 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.072 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -101.5 123.03 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.278 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.79 132.18 11.17 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.76 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.3 142.4 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.745 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.4 p -79.98 88.85 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.55 168.92 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.96 132.48 18.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.32 -85.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 40.28 3.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.407 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.77 29.13 39.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.086 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.84 142.66 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.248 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.66 157.46 60.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.422 2.081 . . . . 0.0 112.414 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -151.5 139.15 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.62 83.38 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.94 117.11 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 78.9 m -113.22 106.12 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.7 OUTLIER -155.98 117.95 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.546 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' N ' ' A' ' 34' ' ' THR . 52.7 ttt-85 -160.5 35.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.83 54.57 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.939 0.4 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -114.15 1.2 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.898 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.804 0.335 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 3' ' ' ASP . 12.1 p -108.74 -42.05 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HG13 ' A' ' 2' ' ' VAL . 8.1 p-10 -109.8 -38.22 5.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.38 90.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.86 -176.35 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -176.94 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 46.87 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.22 62.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -52.59 -52.96 52.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.09 42.76 15.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.04 -25.95 62.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 16' ' ' SER . 19.8 m -54.32 156.48 5.77 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.431 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.1 -31.8 22.3 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.785 2.323 . . . . 0.0 112.334 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' H ' HD13 ' A' ' 15' ' ' LEU . . . 149.38 42.63 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.661 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.657 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -141.05 21.53 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.789 0.328 . . . . 0.0 111.253 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.487 ' N ' HG21 ' A' ' 12' ' ' VAL . 15.3 p -53.5 -28.36 30.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.143 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -71.67 -51.51 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 t -71.36 -29.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.14 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.71 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.602 ' O ' HG22 ' A' ' 24' ' ' ILE . 5.4 pt20 -90.59 -20.47 22.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.11 -34.58 58.24 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.701 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.79 -39.52 18.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.557 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.4 -39.45 94.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.97 0.414 . . . . 0.0 110.293 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.1 tp -71.49 -49.34 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.499 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.541 ' N ' HG23 ' A' ' 24' ' ' ILE . 89.1 p -63.04 -50.19 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -56.0 -38.25 70.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.1 m -84.68 -10.23 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -85.58 -26.18 26.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -29.45 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -83.11 -16.83 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.356 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.66 28.51 17.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.725 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -152.71 25.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.52 110.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.997 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -100.8 124.41 46.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.376 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.97 133.37 12.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.627 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 143.35 30.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.91 97.05 6.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -96.16 130.77 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 127.05 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -118.41 -81.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.08 3.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.29 31.85 68.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.089 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 108.65 7.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.532 0.206 . . . . 0.0 111.156 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.14 148.4 39.43 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.44 2.093 . . . . 0.0 112.388 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -141.25 175.7 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.1 t -116.91 85.9 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.85 121.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.3 m -114.33 109.33 18.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.884 ' O ' HG22 ' A' ' 34' ' ' THR . 7.3 m-20 -158.92 118.21 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.394 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HB2' ' N ' ' A' ' 34' ' ' THR . 6.6 ttt-85 -160.53 34.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -90.51 139.37 30.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.63 117.51 1.46 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.925 -179.937 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' HB1' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.847 0.356 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.9 p -84.07 59.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 18.6 p-10 -134.04 38.68 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -158.47 35.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.31 146.15 24.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.517 ' HG ' ' CG ' ' A' ' 36' ' ' HIS . 1.2 m -126.38 -73.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 m -102.31 37.48 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.86 -29.02 64.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -59.09 -38.03 78.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 60.6 38.56 18.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.13 32.59 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 16' ' ' SER . 9.1 m -93.01 153.41 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.23 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.58 ' HG2' HD11 ' A' ' 15' ' ' LEU . 12.9 Cg_endo -56.85 -33.79 95.42 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.715 2.276 . . . . 0.0 112.423 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.698 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 140.19 42.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.961 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -154.23 25.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 0.0 110.941 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.721 ' HB3' HG11 ' A' ' 12' ' ' VAL . 81.8 p -78.9 -25.94 43.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.007 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -71.69 -56.65 5.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.5 t -64.88 -42.15 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.1 -22.83 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tp-100 -91.51 -23.85 19.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.45 -33.0 59.14 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.57 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -84.63 -38.82 19.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -65.63 -37.33 86.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.392 . . . . 0.0 110.506 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -72.97 -49.39 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.558 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -66.54 -49.39 66.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 0.0 111.15 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -54.85 -43.64 73.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.2 m -86.56 -6.32 58.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.526 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtpt -84.47 -26.5 28.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -38.76 57.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -69.28 -18.74 63.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.353 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 65.14 30.87 11.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.759 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.48 29.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 114.63 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.007 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.9 t -102.66 128.67 49.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 132.56 11.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 6' ' ' SER . 2.5 m-70 -141.39 124.73 16.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.638 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.9 p -79.93 93.71 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.27 174.55 5.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 126.39 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.28 -85.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.923 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 40.94 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.207 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.01 30.41 42.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.928 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 95.49 37.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.644 0.259 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 120.74 8.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.465 2.11 . . . . 0.0 112.144 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 m -124.91 158.09 34.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.73 94.58 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -79.98 130.68 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.0 m -121.0 103.87 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 5.4 m-20 -156.95 119.21 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -160.6 36.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.191 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.37 51.24 1.87 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.98 70.9 1.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.897 0.38 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.77 -49.86 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.059 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.17 32.78 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -106.03 -31.64 8.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -61.35 138.07 58.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -162.08 71.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t 59.01 20.69 8.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.07 27.85 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.73 -48.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 ttm 63.01 39.79 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -145.82 52.87 1.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.751 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.9 142.76 95.81 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 -43.35 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.15 . . . . 0.0 112.6 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 160.99 -23.3 0.24 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.925 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -107.38 -9.98 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 111.412 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.582 ' N ' HD22 ' A' ' 15' ' ' LEU . 24.3 t -61.0 -27.34 68.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.809 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -51.49 11.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 t -60.52 -38.87 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.73 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.054 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.622 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.3 tm0? -91.73 -24.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.32 -34.74 75.21 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.569 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -84.62 -41.59 16.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.219 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.558 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -63.73 -36.03 82.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.3 tp -74.28 -46.13 45.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.326 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.0 t -66.04 -51.52 57.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -57.29 -40.3 77.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.279 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.67 -10.61 57.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.667 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -83.56 -27.63 29.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 110.708 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.17 -26.69 29.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.01 -14.72 40.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.49 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 58.36 26.05 13.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.58 21.84 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.55 109.37 0.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.957 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -98.28 123.24 42.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.413 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 111.72 3.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.578 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -118.65 150.08 40.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.5 p -83.92 83.59 7.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.607 ' HG3' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -82.33 -176.08 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.98 139.87 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -118.47 -86.77 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.36 29.58 6.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.402 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.06 27.94 10.45 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.116 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.72 147.35 59.08 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.659 0.266 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 147.3 82.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.164 . . . . 0.0 112.392 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -138.19 151.51 47.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.805 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -105.88 79.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 38' ' ' GLU . 7.3 m -80.84 121.81 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.7 m -113.68 108.85 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -158.2 116.96 3.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.583 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 32.7 ttt85 -160.47 33.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.984 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.92 47.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.71 -55.31 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.165 -0.922 . . . . 0.0 110.829 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.76 0.314 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.07 132.85 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -52.69 4.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.44 32.51 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 98.42 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.9 t -95.78 -28.73 14.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 t 63.44 22.25 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 54.24 24.14 4.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.619 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.75 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.9 ttt 66.52 47.95 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -123.07 34.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG11 ' CB ' ' A' ' 16' ' ' SER . 8.6 m -64.99 155.34 84.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.233 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.09 -37.56 14.46 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.58 2.187 . . . . 0.0 112.397 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.42 -16.46 1.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -107.18 26.69 9.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.032 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.463 ' CB ' HG11 ' A' ' 12' ' ' VAL . 89.9 p -73.58 -25.25 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.002 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.21 -52.64 45.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.14 -41.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.33 -24.22 66.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.587 ' O ' HG22 ' A' ' 24' ' ' ILE . 55.5 tt0 -92.71 -23.18 19.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.82 -33.4 60.2 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.581 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.6 pp -85.68 -41.35 15.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.314 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -62.13 -35.85 79.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.47 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.635 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.76 -47.2 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 24' ' ' ILE . 3.9 p -62.65 -52.76 62.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 p -55.84 -47.0 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.394 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.5 m -78.07 -8.12 57.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.716 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -87.75 -25.42 23.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.672 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -50.84 -26.7 6.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.12 -14.38 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.379 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 63.5 32.31 14.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.807 0.337 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -160.76 28.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.61 112.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.033 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -101.22 135.0 43.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 132.16 11.15 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.764 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -141.64 140.19 33.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.1 p -79.91 89.68 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.982 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.63 106.94 19.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.61 160.02 26.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -142.99 -80.29 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.27 39.31 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.613 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.24 26.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.65 98.92 27.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 111.033 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 91.95 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.475 2.117 . . . . 0.0 112.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -86.42 145.43 26.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.09 90.99 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -79.98 140.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.33 110.09 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 8.5 p-10 -160.14 117.55 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.438 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.4 ttt85 -160.27 33.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.204 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.74 123.38 33.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.83 94.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.4 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 t 64.17 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.9 -58.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -179.48 37.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m 178.5 162.7 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.9 p -106.84 -37.49 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 m -70.52 -52.25 23.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.57 36.3 19.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.22 87.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mtm -81.32 -60.01 2.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -144.63 45.23 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 16' ' ' SER . 31.7 t -133.13 137.29 29.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.678 ' HG2' HD23 ' A' ' 15' ' ' LEU . 9.8 Cg_endo -52.93 -73.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.602 2.202 . . . . 0.0 112.373 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.58 29.56 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.683 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -121.83 -1.1 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.591 0.234 . . . . 0.0 111.392 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.482 ' HB3' HG21 ' A' ' 12' ' ' VAL . 1.5 p -60.91 -28.04 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.651 0.262 . . . . 0.0 111.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -49.71 70.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.41 -33.89 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.13 69.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.196 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.2 pt20 -91.66 -24.45 19.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.53 -31.78 71.08 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.603 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -86.28 -44.7 11.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.269 -0.466 . . . . 0.0 110.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.43 -34.8 72.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.608 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.724 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.11 -45.32 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.227 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 53.3 p -62.41 -49.81 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.3 m -63.21 -47.48 82.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.367 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.16 -20.78 64.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -87.39 -19.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.693 0.283 . . . . 0.0 111.222 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.256 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -80.19 -12.49 59.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.92 32.5 13.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.867 0.365 . . . . 0.0 110.823 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -159.72 28.11 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.5 112.1 0.51 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.993 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -96.81 129.84 44.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.96 138.81 20.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.69 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -154.82 150.38 27.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.688 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 p -92.98 78.19 4.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 -170.07 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 142.46 23.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -81.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.29 35.17 3.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.412 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 29.68 23.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.122 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -148.18 147.17 25.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.291 . . . . 0.0 111.06 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.99 162.39 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.619 2.213 . . . . 0.0 112.328 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -154.42 143.44 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.9 79.78 4.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' HIS . 27.2 m -79.96 136.23 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.4 m -133.6 108.34 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -160.01 117.12 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.7 OUTLIER -160.64 39.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.041 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -95.73 119.14 33.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.07 -65.16 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.821 0.344 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.45 144.08 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -61.35 141.78 57.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 60.11 160.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -101.43 94.26 5.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.04 27.08 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t 57.51 27.37 13.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 49.35 27.59 2.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.302 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.45 -62.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.4 ttt 54.81 26.8 8.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.96 -15.91 20.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 16' ' ' SER . 24.4 m -116.21 70.47 4.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 111.099 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 57.91 5.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.67 2.246 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.96 -57.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -26.4 14.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HG23 ' A' ' 12' ' ' VAL . 3.4 t -54.67 -27.48 40.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -75.32 -45.4 39.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.805 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -31.14 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.019 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -68.48 -27.35 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.045 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -90.66 -23.46 20.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -32.58 62.6 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.526 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -83.72 -42.01 17.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.325 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.601 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -64.76 -37.78 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.531 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.3 tp -71.06 -47.62 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.527 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.9 t -67.13 -50.85 59.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -52.62 -42.29 64.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -84.81 -13.27 51.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.322 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.23 -25.46 51.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.735 0.303 . . . . 0.0 110.785 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -39.62 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.32 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.0 -18.23 60.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.276 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.07 31.95 10.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 m -159.26 26.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.082 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.64 109.69 0.41 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.35 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.0 t -97.68 126.28 42.93 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 135.08 14.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.805 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -149.33 135.99 19.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 45' ' ' THR . 19.7 p -79.95 102.67 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -105.47 133.33 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -120.65 112.71 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -97.12 -81.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.731 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 22.33 27.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.316 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.93 5.47 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.055 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -132.27 109.31 13.75 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.595 0.236 . . . . 0.0 111.055 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 87.82 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' CYS . 10.5 t -86.8 164.72 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 89.09 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.95 134.95 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.3 m -121.04 113.1 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.994 0.426 . . . . 0.0 111.384 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 1.6 m-20 -159.77 116.14 2.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.638 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 2.2 tpt180 -160.68 39.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -93.63 88.59 5.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.4 162.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.705 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.841 0.353 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.4 p -163.23 43.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.26 107.35 18.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -118.18 -51.66 2.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.92 176.69 9.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 p -113.77 -55.73 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 m -97.85 38.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.58 34.79 1.77 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.27 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.41 -33.9 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 mtp 60.08 35.81 21.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 12' ' ' VAL . 34.3 p-10 -111.25 29.16 8.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 11' ' ' ASP . 5.2 m -159.56 55.0 0.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.071 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.54 56.05 5.41 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.686 2.258 . . . . 0.0 112.466 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.538 ' C ' HD23 ' A' ' 15' ' ' LEU . . . -124.27 -17.59 2.95 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.945 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -178.35 -33.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -45.43 -29.48 1.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.321 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -48.24 76.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.08 -32.67 33.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.43 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.978 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.6 pt20 -93.41 -24.71 17.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.65 -36.3 87.56 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.338 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -85.76 -40.38 16.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.981 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 22' ' ' LEU . 3.4 m -62.99 -35.49 80.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.733 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.25 -45.08 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 24' ' ' ILE . 93.6 p -61.23 -43.96 98.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.68 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -44.52 97.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.2 m -71.51 -28.84 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -75.97 -20.21 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.559 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.82 -25.73 4.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -96.06 -10.56 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.613 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m120 66.29 33.3 7.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.042 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -163.8 30.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.74 114.3 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.117 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.1 t -98.42 140.2 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 114.21 3.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.619 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -121.33 130.45 53.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.06 96.44 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 45' ' ' THR . 4.9 mm-40 -93.84 132.52 38.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.28 118.16 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -104.2 -81.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.26 43.44 2.93 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.86 47.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.299 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -122.71 89.41 50.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.45 153.09 70.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' GLU . 12.4 t -160.03 171.68 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.1 m -126.22 108.83 11.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.798 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 m -98.75 148.97 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -116.37 100.88 8.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.761 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.908 ' O ' HG22 ' A' ' 34' ' ' THR . 1.0 OUTLIER -148.23 106.16 3.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -160.69 42.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.781 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -96.62 75.02 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.73 -102.91 2.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 2' ' ' VAL . 16.1 m -144.21 94.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.78 157.14 6.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -108.19 168.89 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.47 135.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -113.64 -50.42 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.53 43.34 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.059 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.1 -29.61 8.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.853 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.86 11.65 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.279 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.2 9.59 7.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.48 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.557 HG12 ' OG ' ' A' ' 16' ' ' SER . 3.5 m 38.85 90.72 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.52 -15.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.366 2.044 . . . . 0.0 112.404 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.37 -11.67 6.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.72 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 -29.95 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.828 0.347 . . . . 0.0 111.056 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.557 ' OG ' HG12 ' A' ' 12' ' ' VAL . 75.2 p -53.21 -28.84 28.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.139 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -43.12 62.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.76 -31.12 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.43 70.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.591 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.5 pt20 -91.47 -22.37 20.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.06 -30.83 64.86 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.575 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -86.58 -42.91 13.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.306 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.632 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.701 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.31 -45.4 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.2 m -61.74 -51.46 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 111.098 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 p -58.34 -49.97 75.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 m -70.9 -14.91 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 24' ' ' ILE . 2.4 tppt? -86.13 -23.66 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.28 -28.51 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.29 -17.14 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.355 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.76 26.64 13.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -154.98 26.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.6 110.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.921 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.896 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -95.86 128.22 42.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.03 125.5 6.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.757 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.8 133.96 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.613 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.19 92.41 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.058 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.7 115.58 22.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.3 115.13 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -81.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.715 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.21 39.73 3.08 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.278 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.01 31.87 33.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -132.07 89.2 38.71 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.64 148.7 90.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.592 2.195 . . . . 0.0 112.134 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -142.16 137.77 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.89 78.5 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.93 133.61 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 39.0 m -124.24 107.43 11.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -157.25 116.47 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 8.9 ttt85 -160.5 34.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.86 80.59 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.24 -31.08 2.3 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.425 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.908 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.8 0.333 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.37 90.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -168.94 55.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -107.3 147.33 30.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.25 155.71 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 31.22 6.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -119.38 36.05 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.767 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.3 49.59 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.42 -54.4 1.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 ttm 59.98 30.58 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -87.29 -26.61 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 16' ' ' SER . 5.7 m -54.1 161.07 2.0 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 72.4 Cg_exo -48.62 -25.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.609 2.206 . . . . 0.0 112.468 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.02 31.04 0.97 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.756 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.71 -0.98 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.487 0.184 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.776 ' CB ' HG21 ' A' ' 12' ' ' VAL . 17.1 m -64.58 -30.76 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -44.77 80.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -76.39 -33.02 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.57 -23.67 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -92.91 -25.17 18.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.67 64.56 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.408 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -84.35 -39.88 18.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.115 -0.543 . . . . 0.0 110.214 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.593 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -63.61 -39.93 95.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.324 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.5 tp -70.16 -47.92 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.357 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 24' ' ' ILE . 7.8 m -64.72 -56.16 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.306 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -31.62 63.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -90.43 -12.12 38.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -83.14 -27.67 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.599 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.06 -29.03 69.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.487 ' NE2' ' HA3' ' A' ' 33' ' ' GLY . 5.2 pt20 -74.99 -7.4 53.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.501 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 m120 50.92 32.46 7.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 111.565 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -166.3 31.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA3' ' NE2' ' A' ' 30' ' ' GLN . . . -160.57 114.71 0.62 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.144 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.6 t -102.49 128.95 48.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.62 126.63 7.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -131.1 129.8 42.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.335 . . . . 0.0 110.602 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.23 92.44 8.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -84.02 157.64 21.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -158.81 116.08 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -106.79 -82.97 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.33 32.8 4.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.244 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.18 30.78 13.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.092 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 116.11 30.02 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.607 0.241 . . . . 0.0 110.949 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 105.61 2.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.487 2.124 . . . . 0.0 112.299 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -93.73 141.67 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 82.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 36' ' ' HIS . 31.1 m -81.53 161.52 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.7 m -155.77 106.73 2.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 11.6 t70 -160.21 120.36 2.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 3.4 ttt-85 -160.61 40.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.733 0.302 . . . . 0.0 111.252 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -96.31 101.78 13.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.45 85.4 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 2' ' ' VAL . 14.4 p -124.84 21.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 p30 178.19 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 114.66 10.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.956 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 m -118.17 45.28 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 m -154.4 30.67 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.4 p -51.82 -59.96 3.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.284 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 54.82 21.64 3.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.479 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.52 6.89 5.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.78 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.2 tpt 46.5 29.14 0.85 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.72 0.295 . . . . 0.0 111.352 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -177.89 60.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 16' ' ' SER . 27.0 m -64.92 112.55 8.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.298 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 16' ' ' SER . 86.7 Cg_endo -84.59 -29.81 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.628 2.218 . . . . 0.0 112.493 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.83 -36.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.333 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.724 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.74 32.1 1.82 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.009 0.405 . . . . 0.0 111.905 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.672 ' HB3' HG12 ' A' ' 12' ' ' VAL . 47.2 t -81.35 -32.97 32.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.663 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -43.31 84.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.91 -31.5 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.07 -30.47 70.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.614 ' O ' HG22 ' A' ' 24' ' ' ILE . 10.8 pt20 -91.76 -24.16 19.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.04 -31.13 64.54 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.482 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.69 -40.69 15.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.37 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.47 -36.15 82.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.359 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.8 tp -75.52 -47.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.628 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' HG23 ' A' ' 24' ' ' ILE . 30.3 t -65.79 -46.64 77.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.155 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -59.38 -47.0 87.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.356 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.1 -14.47 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.529 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -82.31 -25.24 34.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.96 -29.72 43.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.268 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -81.6 -13.88 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.441 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m120 58.87 25.1 13.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -148.56 21.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 110.88 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.055 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.8 t -97.79 126.87 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.653 0.263 . . . . 0.0 110.367 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.81 130.95 10.18 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.609 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -141.41 152.57 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.9 m -79.95 88.52 5.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.004 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.86 94.65 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 131.85 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -77.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.22 25.45 12.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 32.77 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.322 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 81.91 14.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.702 0.287 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.22 107.29 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.616 2.211 . . . . 0.0 112.094 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 m -120.32 155.92 32.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 88.9 2.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.97 125.57 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.2 m -117.62 107.23 13.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.904 ' O ' HG22 ' A' ' 34' ' ' THR . 14.1 p-10 -154.05 116.03 4.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 35.4 ttt180 -160.16 28.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.88 54.84 3.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.19 35.33 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.549 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.815 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.04 -47.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -162.43 -178.67 6.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.41 34.85 3.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 t 60.05 88.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -66.53 0.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -126.19 66.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.64 31.15 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.58 -56.65 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.1 ttt 60.24 31.11 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -130.48 35.79 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.509 HG11 ' CB ' ' A' ' 16' ' ' SER . 12.1 m -79.7 154.25 75.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 15' ' ' LEU . 15.0 Cg_endo -57.62 -37.99 95.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.658 2.239 . . . . 0.0 112.347 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 137.15 37.84 0.16 Allowed Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.023 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -146.15 -21.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.544 ' H ' HD22 ' A' ' 15' ' ' LEU . 27.4 t -56.18 -23.85 37.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.651 0.263 . . . . 0.0 111.174 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -67.22 -48.04 69.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.93 -32.78 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -25.11 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.0 pt20 -92.86 -24.71 18.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.84 -34.48 62.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.443 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -84.81 -40.24 17.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.57 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.6 m -63.9 -35.7 81.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.1 tp -75.44 -46.93 36.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.545 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.3 m -66.49 -51.1 60.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 t -60.0 -39.8 87.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 94.9 m -82.24 -16.44 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -80.14 -27.65 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.642 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.61 -27.61 67.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.299 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 27' ' ' CYS . 4.5 pt20 -79.72 -1.18 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.556 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.19 31.91 2.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.839 0.352 . . . . 0.0 111.667 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.73 29.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.82 114.24 0.6 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.009 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.7 t -104.28 123.84 48.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.909 0.354 . . . . 0.0 110.397 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.8 103.33 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.0 m170 -112.73 142.83 44.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.326 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.6 p -81.48 86.41 6.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -167.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -159.58 120.88 3.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -98.71 -86.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 28.12 7.8 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.381 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.58 8.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.107 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.93 139.88 20.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.642 0.258 . . . . 0.0 111.012 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.74 144.59 42.73 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.568 2.179 . . . . 0.0 112.408 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -133.19 141.52 48.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.776 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.12 74.17 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 36' ' ' HIS . 5.5 m -80.88 125.98 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.5 m -119.75 108.14 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 111.374 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 34' ' ' THR . 12.7 p-10 -160.0 119.7 2.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.602 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.444 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.8 ttt85 -160.56 39.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.69 54.61 1.33 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.03 81.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.415 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' C ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.6 p 43.79 60.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.636 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 71.71 57.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.256 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 21.4 m-85 -147.62 -47.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.787 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 t -142.03 169.98 16.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.782 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.52 -82.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m 49.36 67.23 0.92 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.03 41.27 1.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -108.63 -40.3 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtp 59.26 50.51 7.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.3 33.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -117.54 115.0 37.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.45 -52.5 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.436 2.09 . . . . 0.0 112.388 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.66 36.46 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.572 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.12 -16.52 15.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 111.251 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -20.69 41.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -79.34 -49.29 12.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.033 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.55 -38.4 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.078 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.56 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.5 tt0 -92.4 -21.99 19.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.08 -33.5 59.39 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.49 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.91 -42.35 15.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.093 -0.553 . . . . 0.0 110.375 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.571 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -61.71 -37.04 82.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -73.76 -49.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.229 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -62.3 -52.13 64.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.3 p -53.87 -44.55 70.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.55 -8.28 59.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.56 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -85.1 -26.63 26.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -50.4 -26.61 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.483 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -86.23 -17.34 35.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.61 33.6 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 m -161.0 29.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.6 113.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.005 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.0 t -101.51 129.95 47.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 135.76 15.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.544 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.51 148.49 25.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.05 97.31 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -110.27 145.97 36.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 148.39 51.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.3 -81.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.33 48.68 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.897 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.37 31.04 76.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.976 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.91 124.84 14.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.491 0.186 . . . . 0.0 111.136 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.04 154.11 34.96 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.426 2.084 . . . . 0.0 112.223 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.8 m -158.04 155.4 29.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.16 91.56 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.9 136.22 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -128.56 106.86 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 p-10 -157.69 119.04 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.795 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt85 -160.42 35.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.331 . . . . 0.0 111.064 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -90.04 78.11 6.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.48 -166.63 53.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.0 mtt-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 3' ' ' ASP . 28.4 t -117.01 157.57 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 2' ' ' VAL . 2.1 p30 -121.39 154.45 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.76 -37.75 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -80.93 -178.02 6.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.9 p -104.46 -22.72 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.27 73.26 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.29 25.03 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.42 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.09 -33.61 12.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.96 30.52 20.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.957 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -108.41 30.63 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.773 HG21 ' HB2' ' A' ' 16' ' ' SER . 11.4 m -109.55 158.73 33.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -50.15 -26.03 14.23 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.693 2.262 . . . . 0.0 112.513 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.76 81.82 0.77 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.268 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.74 -27.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.608 0.242 . . . . 0.0 111.337 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.773 ' HB2' HG21 ' A' ' 12' ' ' VAL . 2.4 m -42.25 -31.31 0.38 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.635 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -53.48 37.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.76 -43.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.726 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.74 -22.16 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.651 ' O ' HG22 ' A' ' 24' ' ' ILE . 11.2 tm0? -90.79 -25.74 19.8 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.97 -33.82 70.45 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.504 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.01 -38.07 21.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.394 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.499 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -66.67 -38.16 86.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.429 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -70.97 -49.44 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.49 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.6 m -67.63 -49.7 61.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.796 0.332 . . . . 0.0 111.053 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.2 t -53.08 -41.46 64.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.223 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m -87.01 -10.36 53.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -79.81 -26.5 40.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -38.16 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.41 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -72.27 -14.59 61.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 t30 59.24 27.49 16.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 22.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.11 114.23 0.6 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.144 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.8 t -101.44 129.16 47.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.73 120.68 5.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.669 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.4 139.5 53.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 110.679 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 p -90.42 88.46 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.66 143.54 27.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.745 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -143.66 128.07 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -110.57 -82.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.28 35.5 3.8 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.55 22.24 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.167 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -131.27 116.01 16.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.192 . . . . 0.0 110.996 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.31 156.7 50.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.388 2.059 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.4 m -147.5 148.72 31.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.5 t -105.93 79.94 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.962 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.7 m -79.93 129.14 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.686 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m -117.57 106.53 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.019 0.438 . . . . 0.0 111.501 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -156.25 115.49 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.239 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -160.58 53.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 111.232 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.4 m -87.2 56.0 3.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.06 118.88 3.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.615 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.803 0.335 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 2' ' ' VAL . 11.6 m -132.09 114.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 60.61 86.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -85.81 -30.44 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 t -97.06 39.62 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -138.47 62.72 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.9 m 60.82 47.53 7.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.14 30.23 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -49.02 9.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.96 29.45 18.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.09 -24.61 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.988 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.759 HG21 ' CB ' ' A' ' 16' ' ' SER . 15.0 m -54.2 154.97 7.28 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.812 ' HG2' HD11 ' A' ' 15' ' ' LEU . 8.5 Cg_endo -51.12 -24.77 15.39 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.779 2.319 . . . . 0.0 112.455 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 135.62 47.77 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.084 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.812 HD11 ' HG2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -158.41 27.77 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.712 0.292 . . . . 0.0 111.064 179.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.759 ' CB ' HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -68.43 -28.61 67.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.057 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -63.51 -48.24 78.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.07 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.42 -29.56 68.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.594 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.5 pt20 -91.41 -22.19 20.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.39 62.51 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.554 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.1 -42.65 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.18 -0.51 . . . . 0.0 110.432 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.714 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.78 -41.24 97.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.8 tp -69.32 -47.39 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -62.97 -53.89 46.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -53.24 -37.14 61.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 1.2 m -82.61 -17.53 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.305 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.78 -22.98 42.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -31.23 16.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.517 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -85.51 -18.61 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.685 0.279 . . . . 0.0 111.486 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 t30 66.42 29.53 9.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.893 0.378 . . . . 0.0 110.962 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.61 29.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.62 122.17 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.542 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 14.9 t -110.68 135.19 51.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 110.245 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -85.6 108.81 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.685 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' HB3' HG22 ' A' ' 47' ' ' VAL . 1.6 t60 -115.65 139.94 49.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.02 89.49 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.55 168.04 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -145.28 109.84 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -86.17 -85.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.773 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.3 24.66 15.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.384 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.22 29.85 6.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.059 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -127.55 117.7 21.31 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.98 94.18 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.469 2.113 . . . . 0.0 112.183 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.5 m -99.62 155.06 17.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.3 t -108.12 100.46 9.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 36' ' ' HIS . 29.7 m -79.95 143.12 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.829 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t -118.18 99.06 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.132 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 27.2 t70 -160.16 119.61 2.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.739 0.304 . . . . 0.0 111.675 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.2 ttt85 -160.6 28.73 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.8 52.79 2.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.952 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.63 -142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.536 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.826 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.786 0.327 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.22 115.97 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.18 164.61 27.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.98 41.28 14.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -137.79 114.31 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.06 -74.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.42 -35.89 82.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 -31.14 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -78.51 -24.59 45.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.2 mtp 65.27 30.06 11.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.764 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.16 38.93 4.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -105.88 92.76 6.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.59 58.06 5.75 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.727 2.284 . . . . 0.0 112.669 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.687 ' C ' HD13 ' A' ' 15' ' ' LEU . . . -131.44 -58.47 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.687 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -159.33 25.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.676 0.274 . . . . 0.0 111.131 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -89.02 -25.06 22.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.09 -41.72 49.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.059 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.21 -32.96 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.88 -30.35 61.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tt0 -92.82 -22.83 19.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.27 -34.34 64.2 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.58 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -85.32 -41.74 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.236 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.726 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -62.74 -36.24 82.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.419 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 35' ' ' GLY . 10.7 tp -75.39 -44.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.178 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 87.0 p -59.67 -56.86 16.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.81 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t -55.91 -42.19 75.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 m -70.23 -22.02 62.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -77.82 -26.89 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.94 -33.73 64.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 9.9 pt20 -87.0 -20.12 27.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 76.32 -41.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.74 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.31 36.5 0.79 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.655 0.264 . . . . 0.0 111.15 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 50' ' ' ARG . . . -160.79 122.57 1.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.085 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 49' ' ' ASP . 6.7 t -103.25 130.06 50.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.683 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -92.91 111.76 4.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -132.17 159.32 39.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.1 t -95.26 93.39 7.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -173.91 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.41 132.79 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -108.35 -85.2 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.34 43.72 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.276 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.22 29.47 56.4 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.982 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.87 148.88 71.21 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.716 0.293 . . . . 0.0 110.992 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 133.99 22.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.605 2.203 . . . . 0.0 112.406 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 m -138.21 157.19 46.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.65 98.44 6.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 145.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 t -131.33 97.88 4.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.839 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -159.97 121.77 3.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.602 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.6 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 24.4 ttp180 -160.03 28.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 t -88.37 125.63 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.47 169.17 6.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.927 -179.981 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 m -98.1 30.92 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -157.58 143.36 17.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 8' ' ' ALA . 49.6 p90 -106.35 139.32 41.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.7 m -88.55 -54.63 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 p -170.61 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 38.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 4' ' ' PHE . . . -57.09 -57.4 12.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' O ' ' CB ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -73.18 -49.24 29.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.822 ' O ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 83.33 -50.14 0.15 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 p30 43.46 33.16 0.59 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.115 0.483 . . . . 0.0 110.623 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 16' ' ' SER . 29.4 m -127.96 137.13 30.13 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.192 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.7 -61.01 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.697 2.264 . . . . 0.0 112.527 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.89 36.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.92 -21.4 12.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.865 ' HB2' HG21 ' A' ' 12' ' ' VAL . 11.2 t -53.29 -25.04 13.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -43.88 65.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 t -83.15 -34.09 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.81 -26.23 66.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.643 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -92.6 -31.92 14.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.81 -32.76 83.85 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.586 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.6 pp -84.99 -41.6 15.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.747 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -64.1 -34.82 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.0 tp -75.49 -46.74 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.475 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.501 ' N ' HG23 ' A' ' 24' ' ' ILE . 16.8 m -66.97 -48.0 69.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.232 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -60.64 -42.34 96.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.585 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m -82.47 -14.71 54.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.759 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -81.87 -26.86 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -24.61 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.427 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -86.58 -17.21 34.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.437 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.0 30.33 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -157.61 27.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 113.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.027 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.7 t -97.86 128.66 44.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 129.55 9.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.825 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.9 m80 -141.48 118.35 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.634 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.7 p -80.0 94.35 5.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 171.4 9.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.57 131.55 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -87.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.46 25.99 11.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.376 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 28.27 7.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 124.67 26.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.516 0.198 . . . . 0.0 111.048 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.56 86.73 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 m -80.06 145.25 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 89.89 3.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 36' ' ' HIS . 30.7 m -80.01 162.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.838 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' THR . 80.2 m -152.52 109.11 3.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.892 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 t70 -160.0 119.06 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HB2' ' N ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -160.54 35.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -92.66 52.56 1.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 161.65 13.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.934 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 3' ' ' ASP . 7.4 p -122.48 -44.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.081 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.7 t0 81.85 -13.17 0.9 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.825 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 3' ' ' ASP . 50.3 m-85 -146.68 83.71 1.6 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.3 -66.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m 61.34 76.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.26 44.67 1.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.743 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.21 24.97 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.223 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.82 -51.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 59.9 36.33 21.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.34 40.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.979 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.01 147.02 95.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.681 ' HG2' HD21 ' A' ' 15' ' ' LEU . 18.2 Cg_endo -60.8 -37.96 74.19 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.799 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 145.27 45.1 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.33 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.799 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -135.53 -34.92 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.793 0.297 . . . . 0.0 111.157 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.5 t -56.13 -23.82 36.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.349 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -65.92 -40.94 91.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.9 t -83.9 -34.06 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.88 -36.35 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.4 tm0? -90.75 -21.03 21.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.5 -34.33 78.95 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.425 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.34 -42.2 14.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.045 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.618 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.7 -34.17 76.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.18 -46.99 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.021 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 45.2 m -63.45 -48.81 76.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -57.4 -49.66 75.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.349 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.77 -13.33 60.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -81.83 -26.62 34.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -36.05 25.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -72.97 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.353 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 64.59 26.62 13.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -153.73 23.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.49 113.38 0.56 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.935 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 13.9 t -103.16 134.56 46.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.74 0.305 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.84 130.8 10.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.709 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -139.45 150.95 45.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.92 90.88 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -94.54 88.55 5.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 -178.46 5.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.56 -75.9 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.73 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 15.82 58.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.654 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 29.23 2.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -114.39 85.79 11.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.19 92.24 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.532 2.154 . . . . 0.0 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -98.76 144.57 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.68 94.02 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 38' ' ' GLU . 16.8 m -83.11 126.06 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 83.9 m -116.8 104.5 11.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -154.02 116.0 4.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.634 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.455 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.8 ttp85 -160.41 28.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.051 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.51 161.09 17.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.842 0.353 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.64 -131.94 1.67 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.915 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.794 0.33 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG11 ' HE2' ' A' ' 17' ' ' LYS . 21.5 t -132.91 133.95 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.79 82.33 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 t80 60.21 99.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.75 98.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.492 ' OG ' HG13 ' A' ' 2' ' ' VAL . 1.2 m -59.94 -34.09 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 m -91.6 -34.07 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.992 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.82 35.87 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -158.47 -42.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 12' ' ' VAL . 1.6 mmm -51.09 -26.04 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.368 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 66.38 44.93 2.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.777 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 16' ' ' SER . 13.2 m -134.48 85.0 38.68 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.71 57.86 5.76 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 0.0 112.493 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.732 ' C ' HD13 ' A' ' 15' ' ' LEU . . . -174.21 -43.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.479 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.732 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.64 3.73 23.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 12' ' ' VAL . 41.8 p -59.48 -31.39 69.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HE2' HG11 ' A' ' 2' ' ' VAL . 20.9 mttt -83.04 -52.83 6.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.991 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.92 -37.11 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -60.4 -30.95 69.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.233 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.577 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -92.04 -23.33 19.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.273 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.51 -33.38 61.1 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.544 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.7 pp -84.15 -42.74 15.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.1 -41.23 96.3 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.367 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.6 tp -70.22 -47.86 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.69 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 24' ' ' ILE . 8.6 p -63.65 -55.61 22.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -52.37 -37.97 57.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 3.7 m -80.44 -22.26 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.314 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.8 tptt -73.05 -26.06 61.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -56.25 -22.34 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.686 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -92.61 -9.87 39.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.56 30.07 16.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.197 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 31.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . -161.34 125.52 1.45 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.837 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -116.87 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.687 0.28 . . . . 0.0 110.25 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.44 110.16 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.657 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -119.12 126.45 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 0.0 110.708 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.5 p -80.0 93.7 5.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.87 151.68 19.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.785 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 137.09 9.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.954 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -128.69 -82.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.06 46.95 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.9 31.59 59.88 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -126.69 89.05 53.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.15 124.39 9.5 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.629 2.22 . . . . 0.0 112.325 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 46' ' ' CYS . 49.0 m -130.47 162.36 29.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.427 ' N ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -118.1 100.55 7.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.86 140.18 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.08 93.66 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.92 ' O ' HG22 ' A' ' 34' ' ' THR . 3.1 m-20 -160.35 121.8 3.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB2' ' N ' ' A' ' 34' ' ' THR . 3.7 tmm_? -161.1 60.9 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 m -92.39 149.13 21.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.18 -45.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.504 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.877 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.03 -31.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.38 66.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 16.1 pt20 -91.76 -25.53 19.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.48 -34.05 88.1 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.404 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.74 -41.37 15.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.279 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.585 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.77 -34.15 75.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.592 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.62 -46.88 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.189 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.5 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -63.85 -47.66 79.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.069 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.4 p -60.33 -48.96 79.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 m -73.22 -17.14 61.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.457 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -83.17 -23.03 33.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.92 -31.55 17.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -78.45 -15.26 58.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 m120 67.11 28.15 8.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.0 25.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.63 109.62 0.4 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.057 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -97.39 130.41 44.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.89 125.13 6.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.632 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -131.37 133.45 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.775 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.26 92.35 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -89.11 89.97 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 147.74 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -135.21 -80.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.958 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 23.78 19.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.749 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.7 24.53 7.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.405 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 87.89 25.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 109.07 2.39 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.567 2.178 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -107.17 147.91 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.5 t -109.44 87.97 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.22 133.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -121.89 111.74 17.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 34' ' ' THR . 17.2 p-10 -159.99 115.62 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 tpt180 -160.62 37.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.976 0.417 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.72 -33.54 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.725 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.68 -25.87 68.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 24' ' ' ILE . 27.9 tp60 -92.26 -25.96 18.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -31.73 65.68 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.566 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.88 -39.82 16.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.49 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -63.95 -34.96 79.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.2 tp -77.03 -46.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.515 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 37.5 t -66.45 -47.63 72.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.216 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -61.43 -45.54 93.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.285 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.53 -17.84 59.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.508 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -23.34 34.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 111.061 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.75 -39.12 67.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.23 -15.51 62.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 64.56 29.41 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.99 25.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 112.09 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.072 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -101.5 123.03 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.278 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.79 132.18 11.17 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.76 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.3 142.4 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.745 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.4 p -79.98 88.85 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.55 168.92 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.96 132.48 18.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.32 -85.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 40.28 3.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.407 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.77 29.13 39.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.086 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.84 142.66 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.248 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.66 157.46 60.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.422 2.081 . . . . 0.0 112.414 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -151.5 139.15 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.62 83.38 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.94 117.11 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 78.9 m -113.22 106.12 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.7 OUTLIER -155.98 117.95 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.546 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' N ' ' A' ' 34' ' ' THR . 52.7 ttt-85 -160.5 35.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.939 0.4 . . . . 0.0 110.937 -179.956 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tptt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.837 0.351 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 t -71.36 -29.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.14 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.71 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.602 ' O ' HG22 ' A' ' 24' ' ' ILE . 5.4 pt20 -90.59 -20.47 22.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.11 -34.58 58.24 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.701 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.79 -39.52 18.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.557 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.4 -39.45 94.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.97 0.414 . . . . 0.0 110.293 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.1 tp -71.49 -49.34 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.499 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.541 ' N ' HG23 ' A' ' 24' ' ' ILE . 89.1 p -63.04 -50.19 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -56.0 -38.25 70.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.1 m -84.68 -10.23 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -85.58 -26.18 26.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -29.45 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -83.11 -16.83 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.356 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.66 28.51 17.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.725 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -152.71 25.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.52 110.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.997 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -100.8 124.41 46.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.376 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.97 133.37 12.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.627 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 143.35 30.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.91 97.05 6.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -96.16 130.77 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 127.05 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -118.41 -81.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.08 3.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.29 31.85 68.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.089 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 108.65 7.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.532 0.206 . . . . 0.0 111.156 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.14 148.4 39.43 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.44 2.093 . . . . 0.0 112.388 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -141.25 175.7 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.1 t -116.91 85.9 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.85 121.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.3 m -114.33 109.33 18.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.884 ' O ' HG22 ' A' ' 34' ' ' THR . 7.3 m-20 -158.92 118.21 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.394 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HB2' ' N ' ' A' ' 34' ' ' THR . 6.6 ttt-85 -160.53 34.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.842 0.353 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.5 t -64.88 -42.15 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.1 -22.83 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tp-100 -91.51 -23.85 19.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.45 -33.0 59.14 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.57 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -84.63 -38.82 19.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -65.63 -37.33 86.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.392 . . . . 0.0 110.506 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -72.97 -49.39 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.558 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -66.54 -49.39 66.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 0.0 111.15 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -54.85 -43.64 73.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.2 m -86.56 -6.32 58.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.526 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtpt -84.47 -26.5 28.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -38.76 57.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.28 -18.74 63.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.353 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 65.14 30.87 11.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.759 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.48 29.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 114.63 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.007 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.9 t -102.66 128.67 49.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 132.56 11.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -141.39 124.73 16.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.638 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.9 p -79.93 93.71 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.27 174.55 5.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 126.39 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.28 -85.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.923 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 40.94 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.207 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.01 30.41 42.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.928 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 95.49 37.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.644 0.259 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 120.74 8.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.465 2.11 . . . . 0.0 112.144 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 m -124.91 158.09 34.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.73 94.58 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -79.98 130.68 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.0 m -121.0 103.87 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 5.4 m-20 -156.95 119.21 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -160.6 36.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.191 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.743 0.306 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 t -60.52 -38.87 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.73 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.054 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.622 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.3 tm0? -91.73 -24.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.32 -34.74 75.21 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.569 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -84.62 -41.59 16.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.219 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.558 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -63.73 -36.03 82.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.3 tp -74.28 -46.13 45.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.326 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.0 t -66.04 -51.52 57.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -57.29 -40.3 77.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.279 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.67 -10.61 57.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.667 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -83.56 -27.63 29.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 110.708 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.17 -26.69 29.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.01 -14.72 40.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.49 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 58.36 26.05 13.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.58 21.84 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.55 109.37 0.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.957 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -98.28 123.24 42.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.413 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 111.72 3.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.578 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -118.65 150.08 40.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.5 p -83.92 83.59 7.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.607 ' HG3' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -82.33 -176.08 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.98 139.87 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -118.47 -86.77 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.36 29.58 6.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.402 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.06 27.94 10.45 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.116 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.72 147.35 59.08 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.659 0.266 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 147.3 82.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.164 . . . . 0.0 112.392 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -138.19 151.51 47.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.805 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -105.88 79.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 38' ' ' GLU . 7.3 m -80.84 121.81 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.7 m -113.68 108.85 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -158.2 116.96 3.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.583 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 32.7 ttt85 -160.47 33.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.984 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 110.948 -179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.905 0.384 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.14 -41.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.33 -24.22 66.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.587 ' O ' HG22 ' A' ' 24' ' ' ILE . 55.5 tt0 -92.71 -23.18 19.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.82 -33.4 60.2 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.581 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.6 pp -85.68 -41.35 15.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.314 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -62.13 -35.85 79.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.47 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.76 -47.2 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 24' ' ' ILE . 3.9 p -62.65 -52.76 62.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 p -55.84 -47.0 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.394 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.5 m -78.07 -8.12 57.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.716 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -87.75 -25.42 23.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.672 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -50.84 -26.7 6.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.12 -14.38 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.379 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 63.5 32.31 14.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.807 0.337 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -160.76 28.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.61 112.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.033 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -101.22 135.0 43.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 132.16 11.15 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.764 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -141.64 140.19 33.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.1 p -79.91 89.68 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.982 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.63 106.94 19.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.61 160.02 26.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -142.99 -80.29 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.27 39.31 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.613 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.24 26.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.65 98.92 27.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 111.033 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 91.95 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.475 2.117 . . . . 0.0 112.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -86.42 145.43 26.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.09 90.99 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -79.98 140.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.33 110.09 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 8.5 p-10 -160.14 117.55 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.438 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.4 ttt85 -160.27 33.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.204 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.876 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.41 -33.89 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.13 69.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.196 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.2 pt20 -91.66 -24.45 19.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.53 -31.78 71.08 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.603 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -86.28 -44.7 11.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.269 -0.466 . . . . 0.0 110.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.43 -34.8 72.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.608 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.11 -45.32 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.227 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 53.3 p -62.41 -49.81 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.3 m -63.21 -47.48 82.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.367 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.16 -20.78 64.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -87.39 -19.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.693 0.283 . . . . 0.0 111.222 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.256 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -80.19 -12.49 59.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.92 32.5 13.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.867 0.365 . . . . 0.0 110.823 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -159.72 28.11 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.5 112.1 0.51 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.993 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -96.81 129.84 44.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.96 138.81 20.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.69 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -154.82 150.38 27.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.688 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 p -92.98 78.19 4.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 -170.07 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 142.46 23.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -81.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.29 35.17 3.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.412 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 29.68 23.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.122 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -148.18 147.17 25.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.291 . . . . 0.0 111.06 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.99 162.39 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.619 2.213 . . . . 0.0 112.328 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -154.42 143.44 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.9 79.78 4.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' HIS . 27.2 m -79.96 136.23 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.4 m -133.6 108.34 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -160.01 117.12 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.7 OUTLIER -160.64 39.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.041 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.914 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tptt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -31.14 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.019 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -68.48 -27.35 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.045 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -90.66 -23.46 20.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -32.58 62.6 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.526 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -83.72 -42.01 17.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.325 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.601 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -64.76 -37.78 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.531 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.3 tp -71.06 -47.62 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.527 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.9 t -67.13 -50.85 59.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -52.62 -42.29 64.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -84.81 -13.27 51.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.322 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.23 -25.46 51.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.735 0.303 . . . . 0.0 110.785 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -39.62 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.32 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.0 -18.23 60.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.276 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.07 31.95 10.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 m -159.26 26.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.082 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.64 109.69 0.41 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.35 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.0 t -97.68 126.28 42.93 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 135.08 14.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.805 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -149.33 135.99 19.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 45' ' ' THR . 19.7 p -79.95 102.67 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -105.47 133.33 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -120.65 112.71 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -97.12 -81.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.731 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 22.33 27.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.316 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.93 5.47 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.055 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -132.27 109.31 13.75 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.595 0.236 . . . . 0.0 111.055 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 87.82 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' CYS . 10.5 t -86.8 164.72 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 89.09 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.95 134.95 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.3 m -121.04 113.1 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.994 0.426 . . . . 0.0 111.384 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 1.6 m-20 -159.77 116.14 2.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.638 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 2.2 tpt180 -160.68 39.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.08 -32.67 33.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.43 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.978 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.6 pt20 -93.41 -24.71 17.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.65 -36.3 87.56 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.338 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -85.76 -40.38 16.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.981 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 22' ' ' LEU . 3.4 m -62.99 -35.49 80.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.733 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.25 -45.08 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 24' ' ' ILE . 93.6 p -61.23 -43.96 98.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.68 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -44.52 97.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.2 m -71.51 -28.84 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -75.97 -20.21 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.559 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.82 -25.73 4.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -96.06 -10.56 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.613 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m120 66.29 33.3 7.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.042 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -163.8 30.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.74 114.3 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.117 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.1 t -98.42 140.2 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 114.21 3.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.619 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -121.33 130.45 53.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.06 96.44 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 45' ' ' THR . 4.9 mm-40 -93.84 132.52 38.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.28 118.16 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -104.2 -81.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.26 43.44 2.93 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.86 47.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.299 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -122.71 89.41 50.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.45 153.09 70.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' GLU . 12.4 t -160.03 171.68 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.1 m -126.22 108.83 11.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.798 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 m -98.75 148.97 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -116.37 100.88 8.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.761 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.908 ' O ' HG22 ' A' ' 34' ' ' THR . 1.0 OUTLIER -148.23 106.16 3.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -160.69 42.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.781 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 -179.848 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.76 -31.12 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.43 70.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.591 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.5 pt20 -91.47 -22.37 20.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.06 -30.83 64.86 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.575 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -86.58 -42.91 13.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.306 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.632 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.31 -45.4 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.2 m -61.74 -51.46 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 111.098 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 p -58.34 -49.97 75.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 m -70.9 -14.91 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 24' ' ' ILE . 2.4 tppt? -86.13 -23.66 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.28 -28.51 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.29 -17.14 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.355 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.76 26.64 13.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -154.98 26.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.6 110.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.921 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.896 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -95.86 128.22 42.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.03 125.5 6.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.757 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.8 133.96 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.613 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.19 92.41 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.058 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.7 115.58 22.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.3 115.13 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -81.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.715 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.21 39.73 3.08 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.278 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.01 31.87 33.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -132.07 89.2 38.71 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.64 148.7 90.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.592 2.195 . . . . 0.0 112.134 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -142.16 137.77 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.89 78.5 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.93 133.61 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 39.0 m -124.24 107.43 11.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -157.25 116.47 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 8.9 ttt85 -160.5 34.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -76.39 -33.02 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.57 -23.67 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -92.91 -25.17 18.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.67 64.56 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.408 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -84.35 -39.88 18.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.115 -0.543 . . . . 0.0 110.214 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.593 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -63.61 -39.93 95.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.324 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.5 tp -70.16 -47.92 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.357 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 24' ' ' ILE . 7.8 m -64.72 -56.16 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.306 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -31.62 63.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -90.43 -12.12 38.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -83.14 -27.67 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.599 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.06 -29.03 69.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.99 -7.4 53.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.501 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 m120 50.92 32.46 7.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 111.565 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -166.3 31.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 114.71 0.62 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.144 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.6 t -102.49 128.95 48.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.62 126.63 7.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -131.1 129.8 42.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.335 . . . . 0.0 110.602 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.23 92.44 8.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -84.02 157.64 21.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -158.81 116.08 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -106.79 -82.97 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.33 32.8 4.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.244 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.18 30.78 13.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.092 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 116.11 30.02 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.607 0.241 . . . . 0.0 110.949 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 105.61 2.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.487 2.124 . . . . 0.0 112.299 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -93.73 141.67 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 82.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 36' ' ' HIS . 31.1 m -81.53 161.52 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.7 m -155.77 106.73 2.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 11.6 t70 -160.21 120.36 2.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 3.4 ttt-85 -160.61 40.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.733 0.302 . . . . 0.0 111.252 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.867 0.365 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.91 -31.5 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.07 -30.47 70.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.614 ' O ' HG22 ' A' ' 24' ' ' ILE . 10.8 pt20 -91.76 -24.16 19.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.04 -31.13 64.54 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.482 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.69 -40.69 15.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.37 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.47 -36.15 82.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.359 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.8 tp -75.52 -47.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.628 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' HG23 ' A' ' 24' ' ' ILE . 30.3 t -65.79 -46.64 77.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.155 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -59.38 -47.0 87.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.356 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.1 -14.47 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.529 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -82.31 -25.24 34.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.96 -29.72 43.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.268 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -13.88 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.441 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m120 58.87 25.1 13.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -148.56 21.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 110.88 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.055 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.8 t -97.79 126.87 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.653 0.263 . . . . 0.0 110.367 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.81 130.95 10.18 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.609 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -141.41 152.57 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.9 m -79.95 88.52 5.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.004 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.86 94.65 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 131.85 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -77.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.22 25.45 12.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 32.77 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.322 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 81.91 14.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.702 0.287 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.22 107.29 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.616 2.211 . . . . 0.0 112.094 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 m -120.32 155.92 32.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 88.9 2.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.97 125.57 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.2 m -117.62 107.23 13.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.904 ' O ' HG22 ' A' ' 34' ' ' THR . 14.1 p-10 -154.05 116.03 4.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 35.4 ttt180 -160.16 28.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.878 0.37 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.93 -32.78 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -25.11 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.0 pt20 -92.86 -24.71 18.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.84 -34.48 62.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.443 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -84.81 -40.24 17.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.57 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.6 m -63.9 -35.7 81.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.1 tp -75.44 -46.93 36.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.545 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.3 m -66.49 -51.1 60.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 t -60.0 -39.8 87.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 94.9 m -82.24 -16.44 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -80.14 -27.65 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.642 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.61 -27.61 67.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.299 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.72 -1.18 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.556 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.19 31.91 2.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.839 0.352 . . . . 0.0 111.667 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.73 29.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.82 114.24 0.6 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.009 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.7 t -104.28 123.84 48.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.909 0.354 . . . . 0.0 110.397 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.8 103.33 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.0 m170 -112.73 142.83 44.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.326 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.6 p -81.48 86.41 6.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -167.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -159.58 120.88 3.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -98.71 -86.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 28.12 7.8 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.381 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.58 8.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.107 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.93 139.88 20.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.642 0.258 . . . . 0.0 111.012 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.74 144.59 42.73 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.568 2.179 . . . . 0.0 112.408 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -133.19 141.52 48.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.776 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.12 74.17 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 36' ' ' HIS . 5.5 m -80.88 125.98 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.5 m -119.75 108.14 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 111.374 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 34' ' ' THR . 12.7 p-10 -160.0 119.7 2.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.602 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.444 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.8 ttt85 -160.56 39.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 -179.885 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tttt . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.807 0.337 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.55 -38.4 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.078 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.56 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.5 tt0 -92.4 -21.99 19.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.08 -33.5 59.39 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.49 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.91 -42.35 15.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.093 -0.553 . . . . 0.0 110.375 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.571 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -61.71 -37.04 82.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -73.76 -49.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.229 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -62.3 -52.13 64.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.3 p -53.87 -44.55 70.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.55 -8.28 59.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.56 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -85.1 -26.63 26.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -50.4 -26.61 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.483 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -86.23 -17.34 35.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.61 33.6 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 m -161.0 29.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.6 113.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.005 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.0 t -101.51 129.95 47.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 135.76 15.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.544 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 148.49 25.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.05 97.31 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -110.27 145.97 36.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 148.39 51.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.3 -81.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.33 48.68 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.897 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.37 31.04 76.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.976 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.91 124.84 14.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.491 0.186 . . . . 0.0 111.136 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.04 154.11 34.96 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.426 2.084 . . . . 0.0 112.223 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.8 m -158.04 155.4 29.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.16 91.56 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.9 136.22 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -128.56 106.86 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 p-10 -157.69 119.04 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.795 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt85 -160.42 35.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.331 . . . . 0.0 111.064 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.872 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.76 -43.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.726 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.74 -22.16 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.651 ' O ' HG22 ' A' ' 24' ' ' ILE . 11.2 tm0? -90.79 -25.74 19.8 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.97 -33.82 70.45 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.504 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.01 -38.07 21.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.394 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.499 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -66.67 -38.16 86.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.429 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -70.97 -49.44 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.49 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.6 m -67.63 -49.7 61.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.796 0.332 . . . . 0.0 111.053 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.2 t -53.08 -41.46 64.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.223 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m -87.01 -10.36 53.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -79.81 -26.5 40.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -38.16 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.41 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -72.27 -14.59 61.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 t30 59.24 27.49 16.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 22.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.11 114.23 0.6 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.144 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.8 t -101.44 129.16 47.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.73 120.68 5.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.669 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.4 139.5 53.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 110.679 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 p -90.42 88.46 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.66 143.54 27.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.745 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -143.66 128.07 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -110.57 -82.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.28 35.5 3.8 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.55 22.24 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.167 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -131.27 116.01 16.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.192 . . . . 0.0 110.996 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.31 156.7 50.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.388 2.059 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.4 m -147.5 148.72 31.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.5 t -105.93 79.94 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.962 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.7 m -79.93 129.14 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.686 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m -117.57 106.53 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.019 0.438 . . . . 0.0 111.501 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -156.25 115.49 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.239 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -160.58 53.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 111.232 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 mttt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.07 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.42 -29.56 68.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.594 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.5 pt20 -91.41 -22.19 20.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.39 62.51 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.554 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.1 -42.65 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.18 -0.51 . . . . 0.0 110.432 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.714 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.78 -41.24 97.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.8 tp -69.32 -47.39 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -62.97 -53.89 46.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -53.24 -37.14 61.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 1.2 m -82.61 -17.53 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.305 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.78 -22.98 42.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -31.23 16.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.517 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -85.51 -18.61 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.685 0.279 . . . . 0.0 111.486 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 t30 66.42 29.53 9.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.893 0.378 . . . . 0.0 110.962 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.61 29.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.62 122.17 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.542 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 14.9 t -110.68 135.19 51.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 110.245 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -85.6 108.81 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.685 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' HB3' HG22 ' A' ' 47' ' ' VAL . 1.6 t60 -115.65 139.94 49.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.02 89.49 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.55 168.04 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -145.28 109.84 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -86.17 -85.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.773 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.3 24.66 15.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.384 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.22 29.85 6.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.059 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -127.55 117.7 21.31 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.98 94.18 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.469 2.113 . . . . 0.0 112.183 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.5 m -99.62 155.06 17.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.3 t -108.12 100.46 9.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 36' ' ' HIS . 29.7 m -79.95 143.12 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.829 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t -118.18 99.06 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.132 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 27.2 t70 -160.16 119.61 2.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.739 0.304 . . . . 0.0 111.675 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.2 ttt85 -160.6 28.73 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.952 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.21 -32.96 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.88 -30.35 61.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tt0 -92.82 -22.83 19.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.27 -34.34 64.2 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.58 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -85.32 -41.74 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.236 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.726 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -62.74 -36.24 82.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.419 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 35' ' ' GLY . 10.7 tp -75.39 -44.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.178 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 87.0 p -59.67 -56.86 16.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.81 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t -55.91 -42.19 75.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 m -70.23 -22.02 62.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -77.82 -26.89 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.94 -33.73 64.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 15.7 pt20 -87.0 -20.12 27.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 76.32 -41.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.74 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.31 36.5 0.79 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.655 0.264 . . . . 0.0 111.15 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 50' ' ' ARG . . . -160.79 122.57 1.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.085 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 49' ' ' ASP . 6.7 t -103.25 130.06 50.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.683 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -92.91 111.76 4.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -132.17 159.32 39.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.1 t -95.26 93.39 7.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -173.91 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.41 132.79 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -108.35 -85.2 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.34 43.72 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.276 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.22 29.47 56.4 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.982 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.87 148.88 71.21 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.716 0.293 . . . . 0.0 110.992 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 133.99 22.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.605 2.203 . . . . 0.0 112.406 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 m -138.21 157.19 46.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.65 98.44 6.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 145.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 t -131.33 97.88 4.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.839 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -159.97 121.77 3.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.602 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.6 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 24.4 ttp180 -160.03 28.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.869 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 t -83.15 -34.09 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.81 -26.23 66.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.643 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -92.6 -31.92 14.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.81 -32.76 83.85 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.586 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.6 pp -84.99 -41.6 15.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.747 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -64.1 -34.82 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.0 tp -75.49 -46.74 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.475 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.501 ' N ' HG23 ' A' ' 24' ' ' ILE . 16.8 m -66.97 -48.0 69.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.232 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -60.64 -42.34 96.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.585 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m -82.47 -14.71 54.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.759 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -81.87 -26.86 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -24.61 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.427 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -17.21 34.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.437 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.0 30.33 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -157.61 27.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 113.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.027 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.7 t -97.86 128.66 44.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 129.55 9.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.825 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.9 m80 -141.48 118.35 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.634 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.7 p -80.0 94.35 5.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 171.4 9.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.57 131.55 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -87.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.46 25.99 11.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.376 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 28.27 7.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 124.67 26.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.516 0.198 . . . . 0.0 111.048 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.56 86.73 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 m -80.06 145.25 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 89.89 3.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 36' ' ' HIS . 30.7 m -80.01 162.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.838 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' THR . 80.2 m -152.52 109.11 3.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.892 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 t70 -160.0 119.06 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HB2' ' N ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -160.54 35.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.897 0.38 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.9 t -83.9 -34.06 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.88 -36.35 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.4 tm0? -90.75 -21.03 21.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.5 -34.33 78.95 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.425 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.34 -42.2 14.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.045 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.618 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.7 -34.17 76.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.18 -46.99 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.021 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 45.2 m -63.45 -48.81 76.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -57.4 -49.66 75.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.349 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.77 -13.33 60.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -81.83 -26.62 34.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -36.05 25.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -72.97 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.353 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 64.59 26.62 13.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -153.73 23.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.49 113.38 0.56 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.935 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 13.9 t -103.16 134.56 46.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.74 0.305 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.84 130.8 10.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.709 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -139.45 150.95 45.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.92 90.88 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -94.54 88.55 5.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 -178.46 5.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.56 -75.9 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.73 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 15.82 58.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.654 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 29.23 2.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -114.39 85.79 11.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.19 92.24 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.532 2.154 . . . . 0.0 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -98.76 144.57 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.68 94.02 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 38' ' ' GLU . 16.8 m -83.11 126.06 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 83.9 m -116.8 104.5 11.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -154.02 116.0 4.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.634 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.455 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.8 ttp85 -160.41 28.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.051 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.842 0.353 . . . . 0.0 110.894 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 mttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.92 -37.11 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -60.4 -30.95 69.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.233 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.577 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -92.04 -23.33 19.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.51 -33.38 61.1 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.544 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.7 pp -84.15 -42.74 15.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.1 -41.23 96.3 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.367 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.6 tp -70.22 -47.86 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.69 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 24' ' ' ILE . 8.6 p -63.65 -55.61 22.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -52.37 -37.97 57.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 3.7 m -80.44 -22.26 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.314 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.8 tptt -73.05 -26.06 61.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -56.25 -22.34 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.686 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -92.61 -9.87 39.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.56 30.07 16.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.197 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 31.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . -161.34 125.52 1.45 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.837 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -116.87 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.687 0.28 . . . . 0.0 110.25 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.44 110.16 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.657 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -119.12 126.45 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 0.0 110.708 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.5 p -80.0 93.7 5.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.87 151.68 19.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.785 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 137.09 9.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.954 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -128.69 -82.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.06 46.95 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.9 31.59 59.88 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -126.69 89.05 53.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.15 124.39 9.5 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.629 2.22 . . . . 0.0 112.325 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 46' ' ' CYS . 49.0 m -130.47 162.36 29.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.427 ' N ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -118.1 100.55 7.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.86 140.18 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.08 93.66 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.92 ' O ' HG22 ' A' ' 34' ' ' THR . 3.1 m-20 -160.35 121.8 3.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB2' ' N ' ' A' ' 34' ' ' THR . 3.7 tmm_? -161.1 60.9 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 m . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.836 0.351 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 2' ' ' VAL . 19.2 m -135.42 97.59 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.094 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -90.31 85.85 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -151.33 -47.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -117.24 158.63 23.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -169.95 83.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.8 50.29 5.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.63 30.59 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 -33.42 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.4 ttm 61.44 30.93 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -94.24 -31.96 13.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.703 HG21 ' CB ' ' A' ' 16' ' ' SER . 6.4 m -69.35 159.69 82.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.153 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.39 -35.76 36.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.697 2.265 . . . . 0.0 112.393 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.29 -15.07 3.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.765 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.21 -19.75 61.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.184 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.703 ' CB ' HG21 ' A' ' 12' ' ' VAL . 8.9 t -54.63 -25.54 27.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.263 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -44.14 69.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -79.03 -31.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.38 66.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.082 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 16.1 pt20 -91.76 -25.53 19.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.48 -34.05 88.1 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.404 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.74 -41.37 15.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.279 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.585 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.77 -34.15 75.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.592 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.62 -46.88 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.189 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.5 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -63.85 -47.66 79.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.069 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.4 p -60.33 -48.96 79.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 m -73.22 -17.14 61.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.457 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -83.17 -23.03 33.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.92 -31.55 17.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -78.45 -15.26 58.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 m120 67.11 28.15 8.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.761 0.315 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.0 25.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.63 109.62 0.4 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.057 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -97.39 130.41 44.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.89 125.13 6.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.632 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -131.37 133.45 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.775 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 p -80.26 92.35 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -89.11 89.97 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.65 147.74 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -135.21 -80.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.958 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 23.78 19.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.749 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.7 24.53 7.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.405 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 87.89 25.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 109.07 2.39 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.567 2.178 . . . . 0.0 112.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -107.17 147.91 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.5 t -109.44 87.97 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.22 133.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -121.89 111.74 17.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 34' ' ' THR . 17.2 p-10 -159.99 115.62 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 tpt180 -160.62 37.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.28 131.98 39.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.952 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.49 117.33 4.26 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.811 0.339 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 3' ' ' ASP . 28.2 t -70.8 158.97 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 2' ' ' VAL . 36.4 m-20 61.17 166.71 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -100.05 144.15 29.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.7 p -168.71 77.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -120.51 61.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 t -98.83 33.26 2.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.19 -34.35 15.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -137.06 28.27 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -41.79 78.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.53 35.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.636 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 16' ' ' SER . 21.8 t -78.63 111.87 22.5 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.316 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.6 -25.65 5.32 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.399 2.066 . . . . 0.0 112.117 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 15' ' ' LEU . . . 153.73 44.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.372 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER 173.28 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 111.209 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.691 ' HB3' HG22 ' A' ' 12' ' ' VAL . 4.5 t -46.66 -28.99 1.65 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.38 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -45.44 92.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.976 0.417 . . . . 0.0 110.568 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.72 -33.54 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.725 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.68 -25.87 68.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 24' ' ' ILE . 27.9 tp60 -92.26 -25.96 18.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.36 -31.73 65.68 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.566 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.88 -39.82 16.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.49 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -63.95 -34.96 79.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.951 0.405 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.2 tp -77.03 -46.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.515 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 37.5 t -66.45 -47.63 72.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.216 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -61.43 -45.54 93.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.285 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.53 -17.84 59.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.508 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.71 -23.34 34.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 111.061 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.75 -39.12 67.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.23 -15.51 62.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 64.56 29.41 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.99 25.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 112.09 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.072 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -101.5 123.03 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.278 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.79 132.18 11.17 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.76 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.3 142.4 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.745 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.4 p -79.98 88.85 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.55 168.92 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.96 132.48 18.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.32 -85.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 40.28 3.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.407 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.77 29.13 39.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.086 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.84 142.66 34.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.62 0.248 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.66 157.46 60.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.422 2.081 . . . . 0.0 112.414 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.9 m -151.5 139.15 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.62 83.38 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.94 117.11 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 78.9 m -113.22 106.12 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.7 OUTLIER -155.98 117.95 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.546 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' N ' ' A' ' 34' ' ' THR . 52.7 ttt-85 -160.5 35.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.131 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.83 54.57 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.939 0.4 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -114.15 1.2 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.898 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.804 0.335 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 3' ' ' ASP . 12.1 p -108.74 -42.05 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HG13 ' A' ' 2' ' ' VAL . 8.1 p-10 -109.8 -38.22 5.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.38 90.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.86 -176.35 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -176.94 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 46.87 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.22 62.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -52.59 -52.96 52.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.09 42.76 15.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.04 -25.95 62.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 16' ' ' SER . 19.8 m -54.32 156.48 5.77 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.431 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.1 -31.8 22.3 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.785 2.323 . . . . 0.0 112.334 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' H ' HD13 ' A' ' 15' ' ' LEU . . . 149.38 42.63 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.661 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.657 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -141.05 21.53 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.789 0.328 . . . . 0.0 111.253 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.487 ' N ' HG21 ' A' ' 12' ' ' VAL . 15.3 p -53.5 -28.36 30.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.143 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -71.67 -51.51 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 t -71.36 -29.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.14 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.71 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.602 ' O ' HG22 ' A' ' 24' ' ' ILE . 5.4 pt20 -90.59 -20.47 22.54 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.11 -34.58 58.24 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.701 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.79 -39.52 18.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.557 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.4 -39.45 94.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.97 0.414 . . . . 0.0 110.293 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.1 tp -71.49 -49.34 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.499 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.541 ' N ' HG23 ' A' ' 24' ' ' ILE . 89.1 p -63.04 -50.19 71.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -56.0 -38.25 70.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.1 m -84.68 -10.23 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -85.58 -26.18 26.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -29.45 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.287 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -83.11 -16.83 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.356 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.66 28.51 17.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.725 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -152.71 25.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.52 110.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.997 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -100.8 124.41 46.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.678 0.275 . . . . 0.0 110.376 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.97 133.37 12.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.627 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 143.35 30.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.91 97.05 6.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -96.16 130.77 43.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 127.05 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -118.41 -81.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.08 48.08 3.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.29 31.85 68.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.089 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 108.65 7.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.532 0.206 . . . . 0.0 111.156 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.14 148.4 39.43 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.44 2.093 . . . . 0.0 112.388 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 t -141.25 175.7 9.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.1 t -116.91 85.9 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -79.85 121.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.3 m -114.33 109.33 18.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.884 ' O ' HG22 ' A' ' 34' ' ' THR . 7.3 m-20 -158.92 118.21 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.394 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HB2' ' N ' ' A' ' 34' ' ' THR . 6.6 ttt-85 -160.53 34.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.225 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -90.51 139.37 30.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.63 117.51 1.46 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.925 -179.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' HB1' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.847 0.356 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 2' ' ' VAL . 9.9 p -84.07 59.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' HB1' ' A' ' 1' ' ' ALA . 18.6 p-10 -134.04 38.68 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -158.47 35.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.31 146.15 24.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.517 ' HG ' ' CG ' ' A' ' 36' ' ' HIS . 1.2 m -126.38 -73.69 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 m -102.31 37.48 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.86 -29.02 64.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -59.09 -38.03 78.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 60.6 38.56 18.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.13 32.59 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 16' ' ' SER . 9.1 m -93.01 153.41 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.23 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.58 ' HG2' HD11 ' A' ' 15' ' ' LEU . 12.9 Cg_endo -56.85 -33.79 95.42 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.715 2.276 . . . . 0.0 112.423 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.698 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 140.19 42.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.961 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -154.23 25.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 0.0 110.941 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.721 ' HB3' HG11 ' A' ' 12' ' ' VAL . 81.8 p -78.9 -25.94 43.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.007 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -71.69 -56.65 5.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.5 t -64.88 -42.15 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -63.1 -22.83 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.994 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tp-100 -91.51 -23.85 19.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.45 -33.0 59.14 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.57 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -84.63 -38.82 19.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.398 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -65.63 -37.33 86.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.392 . . . . 0.0 110.506 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -72.97 -49.39 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.558 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -66.54 -49.39 66.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 0.0 111.15 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -54.85 -43.64 73.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.2 m -86.56 -6.32 58.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.526 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtpt -84.47 -26.5 28.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -38.76 57.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.28 -18.74 63.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.353 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 65.14 30.87 11.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.759 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.48 29.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.7 114.63 0.62 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.007 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.9 t -102.66 128.67 49.26 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 132.56 11.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.797 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 6' ' ' SER . 2.5 m-70 -141.39 124.73 16.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.638 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.9 p -79.93 93.71 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.27 174.55 5.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 126.39 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.28 -85.31 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.923 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 40.94 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.207 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.01 30.41 42.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.928 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 95.49 37.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.644 0.259 . . . . 0.0 111.081 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 120.74 8.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.465 2.11 . . . . 0.0 112.144 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 m -124.91 158.09 34.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.73 94.58 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -79.98 130.68 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.0 m -121.0 103.87 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 5.4 m-20 -156.95 119.21 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -160.6 36.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.191 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.37 51.24 1.87 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.98 70.9 1.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.897 0.38 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.77 -49.86 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.059 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -123.17 32.78 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -106.03 -31.64 8.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -61.35 138.07 58.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -162.08 71.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t 59.01 20.69 8.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.215 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.07 27.85 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.73 -48.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 ttm 63.01 39.79 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -145.82 52.87 1.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.751 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 m -67.9 142.76 95.81 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 -43.35 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.15 . . . . 0.0 112.6 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 160.99 -23.3 0.24 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.925 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -107.38 -9.98 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 111.412 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.582 ' N ' HD22 ' A' ' 15' ' ' LEU . 24.3 t -61.0 -27.34 68.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.809 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -51.49 11.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 t -60.52 -38.87 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.73 65.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.054 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.622 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.3 tm0? -91.73 -24.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.32 -34.74 75.21 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.569 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -84.62 -41.59 16.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.219 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.558 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -63.73 -36.03 82.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.3 tp -74.28 -46.13 45.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.326 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.0 t -66.04 -51.52 57.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.08 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -57.29 -40.3 77.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.279 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.67 -10.61 57.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.667 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -83.56 -27.63 29.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 110.708 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.17 -26.69 29.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -87.01 -14.72 40.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.49 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 58.36 26.05 13.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.58 21.84 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.55 109.37 0.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.957 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.6 t -98.28 123.24 42.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.413 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 111.72 3.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.578 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -118.65 150.08 40.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.5 p -83.92 83.59 7.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.607 ' HG3' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -82.33 -176.08 6.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.98 139.87 17.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -118.47 -86.77 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.36 29.58 6.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.402 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.06 27.94 10.45 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.116 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.72 147.35 59.08 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.659 0.266 . . . . 0.0 110.941 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 147.3 82.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.164 . . . . 0.0 112.392 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -138.19 151.51 47.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.805 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -105.88 79.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 38' ' ' GLU . 7.3 m -80.84 121.81 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.7 m -113.68 108.85 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.893 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -158.2 116.96 3.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.583 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 32.7 ttt85 -160.47 33.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.984 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.92 47.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 110.948 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.71 -55.31 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.165 -0.922 . . . . 0.0 110.829 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.76 0.314 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.07 132.85 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -52.69 4.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.44 32.51 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 98.42 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.9 t -95.78 -28.73 14.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 t 63.44 22.25 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 54.24 24.14 4.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.619 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.75 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.9 ttt 66.52 47.95 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -123.07 34.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG11 ' CB ' ' A' ' 16' ' ' SER . 8.6 m -64.99 155.34 84.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.233 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.09 -37.56 14.46 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.58 2.187 . . . . 0.0 112.397 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.42 -16.46 1.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -107.18 26.69 9.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.032 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.463 ' CB ' HG11 ' A' ' 12' ' ' VAL . 89.9 p -73.58 -25.25 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.002 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.21 -52.64 45.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.14 -41.38 75.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.33 -24.22 66.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.587 ' O ' HG22 ' A' ' 24' ' ' ILE . 55.5 tt0 -92.71 -23.18 19.01 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.82 -33.4 60.2 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.581 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.6 pp -85.68 -41.35 15.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.314 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -62.13 -35.85 79.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.47 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.76 -47.2 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 24' ' ' ILE . 3.9 p -62.65 -52.76 62.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 p -55.84 -47.0 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.394 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.5 m -78.07 -8.12 57.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.716 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -87.75 -25.42 23.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.784 0.326 . . . . 0.0 110.672 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -50.84 -26.7 6.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.12 -14.38 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.379 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 63.5 32.31 14.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.807 0.337 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -160.76 28.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.61 112.81 0.54 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.033 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.9 t -101.22 135.0 43.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.8 132.16 11.15 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.764 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -141.64 140.19 33.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.1 p -79.91 89.68 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.982 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.63 106.94 19.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.61 160.02 26.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.006 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -142.99 -80.29 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.27 39.31 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.613 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.24 26.52 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.65 98.92 27.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 111.033 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 91.95 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.475 2.117 . . . . 0.0 112.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -86.42 145.43 26.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.09 90.99 3.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -79.98 140.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.33 110.09 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 34' ' ' THR . 8.5 p-10 -160.14 117.55 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.438 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.4 ttt85 -160.27 33.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.204 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.74 123.38 33.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.83 94.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.4 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 t 64.17 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.9 -58.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -179.48 37.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m 178.5 162.7 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.9 p -106.84 -37.49 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 m -70.52 -52.25 23.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.57 36.3 19.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.22 87.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.0 mtm -81.32 -60.01 2.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -144.63 45.23 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.792 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 16' ' ' SER . 31.7 t -133.13 137.29 29.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.678 ' HG2' HD23 ' A' ' 15' ' ' LEU . 9.8 Cg_endo -52.93 -73.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.602 2.202 . . . . 0.0 112.373 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.58 29.56 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.683 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER -121.83 -1.1 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.591 0.234 . . . . 0.0 111.392 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.482 ' HB3' HG21 ' A' ' 12' ' ' VAL . 1.5 p -60.91 -28.04 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.651 0.262 . . . . 0.0 111.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -49.71 70.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.41 -33.89 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -28.13 69.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.196 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.595 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.2 pt20 -91.66 -24.45 19.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.53 -31.78 71.08 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.603 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -86.28 -44.7 11.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.269 -0.466 . . . . 0.0 110.545 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.43 -34.8 72.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.608 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.11 -45.32 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.227 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 53.3 p -62.41 -49.81 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.3 m -63.21 -47.48 82.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.367 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.16 -20.78 64.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -87.39 -19.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.693 0.283 . . . . 0.0 111.222 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.8 -29.1 64.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.256 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -80.19 -12.49 59.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.359 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.92 32.5 13.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.867 0.365 . . . . 0.0 110.823 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -159.72 28.11 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.5 112.1 0.51 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.993 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.2 t -96.81 129.84 44.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.96 138.81 20.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.69 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -154.82 150.38 27.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.688 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.8 p -92.98 78.19 4.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.974 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 -170.07 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 142.46 23.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.62 -81.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.29 35.17 3.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.412 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 29.68 23.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.122 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -148.18 147.17 25.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.291 . . . . 0.0 111.06 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.99 162.39 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.619 2.213 . . . . 0.0 112.328 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -154.42 143.44 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.9 79.78 4.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' HIS . 27.2 m -79.96 136.23 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.4 m -133.6 108.34 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -160.01 117.12 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.7 OUTLIER -160.64 39.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.041 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -95.73 119.14 33.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.07 -65.16 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.821 0.344 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.45 144.08 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -61.35 141.78 57.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 60.11 160.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -101.43 94.26 5.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.04 27.08 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.02 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t 57.51 27.37 13.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 49.35 27.59 2.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.302 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.45 -62.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.4 ttt 54.81 26.8 8.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.96 -15.91 20.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.243 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 16' ' ' SER . 24.4 m -116.21 70.47 4.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 111.099 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.87 57.91 5.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.67 2.246 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.96 -57.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -26.4 14.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HG23 ' A' ' 12' ' ' VAL . 3.4 t -54.67 -27.48 40.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -75.32 -45.4 39.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.805 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -31.14 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.019 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -68.48 -27.35 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.045 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -90.66 -23.46 20.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -32.58 62.6 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.394 -0.907 . . . . 0.0 111.526 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -83.72 -42.01 17.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.325 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.601 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -64.76 -37.78 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.531 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.3 tp -71.06 -47.62 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.527 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.9 t -67.13 -50.85 59.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.403 . . . . 0.0 111.036 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -52.62 -42.29 64.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -84.81 -13.27 51.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.322 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.23 -25.46 51.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.735 0.303 . . . . 0.0 110.785 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -39.62 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.32 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.0 -18.23 60.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.276 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.07 31.95 10.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 m -159.26 26.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.082 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.64 109.69 0.41 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.35 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.0 t -97.68 126.28 42.93 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.87 135.08 14.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.805 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -149.33 135.99 19.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 45' ' ' THR . 19.7 p -79.95 102.67 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -105.47 133.33 50.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -120.65 112.71 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -97.12 -81.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.731 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.37 22.33 27.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.316 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.31 30.93 5.47 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.055 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -132.27 109.31 13.75 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.595 0.236 . . . . 0.0 111.055 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 87.82 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' CYS . 10.5 t -86.8 164.72 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 89.09 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.95 134.95 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.3 m -121.04 113.1 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.994 0.426 . . . . 0.0 111.384 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 1.6 m-20 -159.77 116.14 2.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.638 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 2.2 tpt180 -160.68 39.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -93.63 88.59 5.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.4 162.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.705 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.841 0.353 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.4 p -163.23 43.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.26 107.35 18.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -118.18 -51.66 2.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.92 176.69 9.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 p -113.77 -55.73 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 m -97.85 38.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.58 34.79 1.77 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.27 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.41 -33.9 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 mtp 60.08 35.81 21.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 12' ' ' VAL . 34.3 p-10 -111.25 29.16 8.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 11' ' ' ASP . 5.2 m -159.56 55.0 0.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.071 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.54 56.05 5.41 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.686 2.258 . . . . 0.0 112.466 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.538 ' C ' HD23 ' A' ' 15' ' ' LEU . . . -124.27 -17.59 2.95 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.945 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -178.35 -33.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 t -45.43 -29.48 1.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.321 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -48.24 76.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -74.08 -32.67 33.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.43 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.978 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.6 pt20 -93.41 -24.71 17.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.65 -36.3 87.56 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.338 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.9 pp -85.76 -40.38 16.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.029 -0.586 . . . . 0.0 109.981 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 22' ' ' LEU . 3.4 m -62.99 -35.49 80.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.511 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.733 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.25 -45.08 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 24' ' ' ILE . 93.6 p -61.23 -43.96 98.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.68 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -44.52 97.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.2 m -71.51 -28.84 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -75.97 -20.21 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.559 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.82 -25.73 4.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -96.06 -10.56 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.613 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m120 66.29 33.3 7.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.042 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -163.8 30.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.74 114.3 0.6 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.117 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.1 t -98.42 140.2 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 114.21 3.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.619 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -121.33 130.45 53.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.06 96.44 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 45' ' ' THR . 4.9 mm-40 -93.84 132.52 38.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.28 118.16 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -104.2 -81.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.26 43.44 2.93 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.86 47.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.299 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -122.71 89.41 50.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 110.876 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.45 153.09 70.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' GLU . 12.4 t -160.03 171.68 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.1 m -126.22 108.83 11.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.798 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 m -98.75 148.97 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -116.37 100.88 8.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.761 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.908 ' O ' HG22 ' A' ' 34' ' ' THR . 1.0 OUTLIER -148.23 106.16 3.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -160.69 42.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.781 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -96.62 75.02 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.73 -102.91 2.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 2' ' ' VAL . 16.1 m -144.21 94.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.112 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.78 157.14 6.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -108.19 168.89 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.47 135.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -113.64 -50.42 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.64 47.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.53 43.34 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.059 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.1 -29.61 8.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.853 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.86 11.65 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.279 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.2 9.59 7.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.48 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.557 HG12 ' OG ' ' A' ' 16' ' ' SER . 3.5 m 38.85 90.72 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.52 -15.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.366 2.044 . . . . 0.0 112.404 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.37 -11.67 6.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.72 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 -29.95 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.828 0.347 . . . . 0.0 111.056 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.557 ' OG ' HG12 ' A' ' 12' ' ' VAL . 75.2 p -53.21 -28.84 28.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.139 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -43.12 62.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.76 -31.12 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.43 70.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.975 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.591 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.5 pt20 -91.47 -22.37 20.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.06 -30.83 64.86 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.575 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -86.58 -42.91 13.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.306 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.632 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.31 -45.4 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.2 m -61.74 -51.46 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 111.098 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 p -58.34 -49.97 75.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 m -70.9 -14.91 62.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.632 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 24' ' ' ILE . 2.4 tppt? -86.13 -23.66 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.679 0.276 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.28 -28.51 53.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.29 -17.14 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.355 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.76 26.64 13.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -154.98 26.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.6 110.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.921 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.896 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -95.86 128.22 42.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.03 125.5 6.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.757 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.8 133.96 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.613 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.19 92.41 8.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.058 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.7 115.58 22.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.3 115.13 17.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -81.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.715 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.21 39.73 3.08 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.278 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.01 31.87 33.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -132.07 89.2 38.71 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.135 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.64 148.7 90.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.592 2.195 . . . . 0.0 112.134 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -142.16 137.77 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.89 78.5 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.93 133.61 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 39.0 m -124.24 107.43 11.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -157.25 116.47 3.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.435 ' HB2' ' N ' ' A' ' 34' ' ' THR . 8.9 ttt85 -160.5 34.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.86 80.59 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.24 -31.08 2.3 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.425 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.908 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.8 0.333 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.37 90.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -168.94 55.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -107.3 147.33 30.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.25 155.71 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 31.22 6.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -119.38 36.05 4.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.767 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.3 49.59 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.42 -54.4 1.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.7 ttm 59.98 30.58 20.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -87.29 -26.61 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 16' ' ' SER . 5.7 m -54.1 161.07 2.0 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.236 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 72.4 Cg_exo -48.62 -25.9 8.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.609 2.206 . . . . 0.0 112.468 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.02 31.04 0.97 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.756 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.71 -0.98 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.487 0.184 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.776 ' CB ' HG21 ' A' ' 12' ' ' VAL . 17.1 m -64.58 -30.76 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -44.77 80.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -76.39 -33.02 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.57 -23.67 64.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -92.91 -25.17 18.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.67 64.56 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.408 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -84.35 -39.88 18.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.115 -0.543 . . . . 0.0 110.214 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.593 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -63.61 -39.93 95.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.324 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.5 tp -70.16 -47.92 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.357 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 24' ' ' ILE . 7.8 m -64.72 -56.16 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.306 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -31.62 63.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -90.43 -12.12 38.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -83.14 -27.67 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 0.0 110.599 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.06 -29.03 69.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.99 -7.4 53.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.501 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.3 m120 50.92 32.46 7.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 111.565 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -166.3 31.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 114.71 0.62 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.144 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 10.6 t -102.49 128.95 48.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.62 126.63 7.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.7 OUTLIER -131.1 129.8 42.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.335 . . . . 0.0 110.602 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.23 92.44 8.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -84.02 157.64 21.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -158.81 116.08 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -106.79 -82.97 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.33 32.8 4.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.244 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.18 30.78 13.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.092 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 116.11 30.02 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.607 0.241 . . . . 0.0 110.949 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 105.61 2.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.487 2.124 . . . . 0.0 112.299 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -93.73 141.67 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 82.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 36' ' ' HIS . 31.1 m -81.53 161.52 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.7 m -155.77 106.73 2.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.325 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 11.6 t70 -160.21 120.36 2.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 3.4 ttt-85 -160.61 40.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.733 0.302 . . . . 0.0 111.252 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -96.31 101.78 13.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.45 85.4 0.29 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 2' ' ' VAL . 14.4 p -124.84 21.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 p30 178.19 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 114.66 10.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.956 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 m -118.17 45.28 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 m -154.4 30.67 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.4 p -51.82 -59.96 3.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.284 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 54.82 21.64 3.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.479 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.52 6.89 5.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.78 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.2 tpt 46.5 29.14 0.85 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.72 0.295 . . . . 0.0 111.352 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -177.89 60.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 16' ' ' SER . 27.0 m -64.92 112.55 8.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.298 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 16' ' ' SER . 86.7 Cg_endo -84.59 -29.81 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.628 2.218 . . . . 0.0 112.493 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.83 -36.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.333 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.724 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -140.74 32.1 1.82 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.009 0.405 . . . . 0.0 111.905 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.672 ' HB3' HG12 ' A' ' 12' ' ' VAL . 47.2 t -81.35 -32.97 32.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.663 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -43.31 84.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.91 -31.5 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.07 -30.47 70.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.614 ' O ' HG22 ' A' ' 24' ' ' ILE . 10.8 pt20 -91.76 -24.16 19.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.04 -31.13 64.54 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.482 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -85.69 -40.69 15.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.37 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.47 -36.15 82.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.992 0.425 . . . . 0.0 110.359 179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.8 tp -75.52 -47.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.628 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' HG23 ' A' ' 24' ' ' ILE . 30.3 t -65.79 -46.64 77.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.881 0.372 . . . . 0.0 111.155 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -59.38 -47.0 87.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.356 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m -78.1 -14.47 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.529 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -82.31 -25.24 34.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.96 -29.72 43.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.268 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -13.88 57.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.441 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 m120 58.87 25.1 13.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -148.56 21.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 110.88 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.055 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.8 t -97.79 126.87 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.653 0.263 . . . . 0.0 110.367 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.81 130.95 10.18 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.609 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -141.41 152.57 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.9 m -79.95 88.52 5.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.004 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.86 94.65 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.95 131.85 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -77.33 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.22 25.45 12.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 32.77 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.322 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 81.91 14.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.702 0.287 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.22 107.29 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.616 2.211 . . . . 0.0 112.094 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 m -120.32 155.92 32.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 88.9 2.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.97 125.57 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.2 m -117.62 107.23 13.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.904 ' O ' HG22 ' A' ' 34' ' ' THR . 14.1 p-10 -154.05 116.03 4.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' N ' ' HA2' ' A' ' 33' ' ' GLY . 35.4 ttt180 -160.16 28.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.107 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.88 54.84 3.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.19 35.33 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.549 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.815 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.04 -47.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -162.43 -178.67 6.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.41 34.85 3.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.836 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 t 60.05 88.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.26 -66.53 0.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -126.19 66.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.64 31.15 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.58 -56.65 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.1 ttt 60.24 31.11 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -130.48 35.79 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.509 HG11 ' CB ' ' A' ' 16' ' ' SER . 12.1 m -79.7 154.25 75.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 15' ' ' LEU . 15.0 Cg_endo -57.62 -37.99 95.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.658 2.239 . . . . 0.0 112.347 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 137.15 37.84 0.16 Allowed Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.023 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -146.15 -21.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.544 ' H ' HD22 ' A' ' 15' ' ' LEU . 27.4 t -56.18 -23.85 37.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.651 0.263 . . . . 0.0 111.174 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -67.22 -48.04 69.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.878 0.37 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.93 -32.78 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -25.11 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.0 pt20 -92.86 -24.71 18.38 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.84 -34.48 62.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.443 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.2 pp -84.81 -40.24 17.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.57 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.6 m -63.9 -35.7 81.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.61 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.1 tp -75.44 -46.93 36.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.545 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.3 m -66.49 -51.1 60.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.899 0.38 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 t -60.0 -39.8 87.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 94.9 m -82.24 -16.44 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -80.14 -27.65 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.642 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.61 -27.61 67.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.299 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -79.72 -1.18 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.556 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.19 31.91 2.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.839 0.352 . . . . 0.0 111.667 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.73 29.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.82 114.24 0.6 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.009 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 49' ' ' ASP . 12.7 t -104.28 123.84 48.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.909 0.354 . . . . 0.0 110.397 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.8 103.33 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.563 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.531 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.0 m170 -112.73 142.83 44.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.326 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.6 p -81.48 86.41 6.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -167.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.754 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -159.58 120.88 3.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -98.71 -86.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.32 28.12 7.8 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.381 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.58 8.57 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.107 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.93 139.88 20.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.642 0.258 . . . . 0.0 111.012 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.74 144.59 42.73 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.568 2.179 . . . . 0.0 112.408 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -133.19 141.52 48.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.776 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.12 74.17 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 36' ' ' HIS . 5.5 m -80.88 125.98 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.761 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.5 m -119.75 108.14 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 111.374 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.889 ' O ' HG22 ' A' ' 34' ' ' THR . 12.7 p-10 -160.0 119.7 2.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.602 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.444 ' HB2' ' N ' ' A' ' 34' ' ' THR . 4.8 ttt85 -160.56 39.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.69 54.61 1.33 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.03 81.94 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.415 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.6 p 43.79 60.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.636 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 71.71 57.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.256 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 21.4 m-85 -147.62 -47.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.787 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.2 t -142.03 169.98 16.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.782 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.52 -82.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.842 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m 49.36 67.23 0.92 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.03 41.27 1.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.231 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -108.63 -40.3 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtp 59.26 50.51 7.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.3 33.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -117.54 115.0 37.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.45 -52.5 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.436 2.09 . . . . 0.0 112.388 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.66 36.46 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.572 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.12 -16.52 15.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 111.251 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -20.69 41.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -79.34 -49.29 12.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.033 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.55 -38.4 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.078 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.56 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.5 tt0 -92.4 -21.99 19.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.08 -33.5 59.39 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.49 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.91 -42.35 15.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.093 -0.553 . . . . 0.0 110.375 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.571 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -61.71 -37.04 82.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.573 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -73.76 -49.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.229 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -62.3 -52.13 64.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.3 p -53.87 -44.55 70.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.004 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -80.55 -8.28 59.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.56 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -85.1 -26.63 26.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.99 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -50.4 -26.61 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.483 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -86.23 -17.34 35.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.61 33.6 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 0.0 110.846 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 m -161.0 29.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.783 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.6 113.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.005 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.0 t -101.51 129.95 47.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 135.76 15.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.544 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 148.49 25.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.8 p -80.05 97.31 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -110.27 145.97 36.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 148.39 51.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.3 -81.74 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.33 48.68 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.897 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.37 31.04 76.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.976 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.91 124.84 14.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.491 0.186 . . . . 0.0 111.136 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.04 154.11 34.96 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.426 2.084 . . . . 0.0 112.223 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.8 m -158.04 155.4 29.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.976 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.16 91.56 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.9 136.22 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -128.56 106.86 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 p-10 -157.69 119.04 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.795 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' N ' ' A' ' 34' ' ' THR . 33.8 ttt85 -160.42 35.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.794 0.331 . . . . 0.0 111.064 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 t -90.04 78.11 6.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.48 -166.63 53.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.0 mtt-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 3' ' ' ASP . 28.4 t -117.01 157.57 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 2' ' ' VAL . 2.1 p30 -121.39 154.45 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -82.76 -37.75 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -80.93 -178.02 6.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.9 p -104.46 -22.72 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.27 73.26 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.29 25.03 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.42 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.09 -33.61 12.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.96 30.52 20.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.957 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -108.41 30.63 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.773 HG21 ' HB2' ' A' ' 16' ' ' SER . 11.4 m -109.55 158.73 33.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -50.15 -26.03 14.23 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.693 2.262 . . . . 0.0 112.513 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.76 81.82 0.77 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.268 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.74 -27.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.608 0.242 . . . . 0.0 111.337 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.773 ' HB2' HG21 ' A' ' 12' ' ' VAL . 2.4 m -42.25 -31.31 0.38 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.635 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -53.48 37.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.76 -43.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.726 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -61.74 -22.16 65.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.651 ' O ' HG22 ' A' ' 24' ' ' ILE . 11.2 tm0? -90.79 -25.74 19.8 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.97 -33.82 70.45 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.504 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.0 pp -84.01 -38.07 21.38 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.394 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.499 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -66.67 -38.16 86.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.429 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 20' ' ' GLN . 7.3 tp -70.97 -49.44 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.49 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.6 m -67.63 -49.7 61.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.796 0.332 . . . . 0.0 111.053 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.2 t -53.08 -41.46 64.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.223 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m -87.01 -10.36 53.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -79.81 -26.5 40.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -38.16 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.41 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -72.27 -14.59 61.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.6 t30 59.24 27.49 16.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 22.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -161.11 114.23 0.6 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.144 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 49' ' ' ASP . 8.8 t -101.44 129.16 47.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -79.73 120.68 5.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.669 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.4 139.5 53.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 110.679 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 p -90.42 88.46 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -87.66 143.54 27.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.745 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -143.66 128.07 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.969 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -110.57 -82.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.28 35.5 3.8 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.435 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.55 22.24 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.167 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -131.27 116.01 16.42 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.192 . . . . 0.0 110.996 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.31 156.7 50.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.388 2.059 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.4 m -147.5 148.72 31.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.5 t -105.93 79.94 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.962 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.7 m -79.93 129.14 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.686 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m -117.57 106.53 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.019 0.438 . . . . 0.0 111.501 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -156.25 115.49 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.239 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -160.58 53.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 111.232 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.4 m -87.2 56.0 3.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.06 118.88 3.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.615 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.803 0.335 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 2' ' ' VAL . 11.6 m -132.09 114.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 60.61 86.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -85.81 -30.44 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 t -97.06 39.62 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -138.47 62.72 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.9 m 60.82 47.53 7.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.14 30.23 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.1 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -49.02 9.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.96 29.45 18.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.09 -24.61 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.988 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.759 HG21 ' CB ' ' A' ' 16' ' ' SER . 15.0 m -54.2 154.97 7.28 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.812 ' HG2' HD11 ' A' ' 15' ' ' LEU . 8.5 Cg_endo -51.12 -24.77 15.39 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.779 2.319 . . . . 0.0 112.455 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 135.62 47.77 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.084 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.812 HD11 ' HG2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -158.41 27.77 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.712 0.292 . . . . 0.0 111.064 179.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.759 ' CB ' HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -68.43 -28.61 67.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.057 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -63.51 -48.24 78.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.07 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.42 -29.56 68.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.594 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.5 pt20 -91.41 -22.19 20.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.39 62.51 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.554 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.5 pp -84.1 -42.65 15.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.18 -0.51 . . . . 0.0 110.432 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.714 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.78 -41.24 97.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 20' ' ' GLN . 10.8 tp -69.32 -47.39 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -62.97 -53.89 46.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.045 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -53.24 -37.14 61.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 1.2 m -82.61 -17.53 44.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.305 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.78 -22.98 42.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -31.23 16.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.517 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -85.51 -18.61 32.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.685 0.279 . . . . 0.0 111.486 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 t30 66.42 29.53 9.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.893 0.378 . . . . 0.0 110.962 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.61 29.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.62 122.17 1.1 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.542 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.922 HG22 ' O ' ' A' ' 49' ' ' ASP . 14.9 t -110.68 135.19 51.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 110.245 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -85.6 108.81 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.685 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' HB3' HG22 ' A' ' 47' ' ' VAL . 1.6 t60 -115.65 139.94 49.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.02 89.49 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.55 168.04 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -145.28 109.84 5.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -86.17 -85.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.773 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.3 24.66 15.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.384 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.22 29.85 6.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.059 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -127.55 117.7 21.31 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.596 0.236 . . . . 0.0 111.024 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.98 94.18 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.469 2.113 . . . . 0.0 112.183 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.5 m -99.62 155.06 17.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.3 t -108.12 100.46 9.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 36' ' ' HIS . 29.7 m -79.95 143.12 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.829 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t -118.18 99.06 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.132 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.922 ' O ' HG22 ' A' ' 34' ' ' THR . 27.2 t70 -160.16 119.61 2.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.739 0.304 . . . . 0.0 111.675 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.2 ttt85 -160.6 28.73 0.16 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.8 52.79 2.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.952 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.63 -142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.536 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.826 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.786 0.327 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.22 115.97 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -136.18 164.61 27.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.98 41.28 14.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -137.79 114.31 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.06 -74.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.42 -35.89 82.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.18 -31.14 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -78.51 -24.59 45.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.2 mtp 65.27 30.06 11.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.764 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.16 38.93 4.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -105.88 92.76 6.68 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.59 58.06 5.75 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.727 2.284 . . . . 0.0 112.669 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.687 ' C ' HD13 ' A' ' 15' ' ' LEU . . . -131.44 -58.47 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.687 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -159.33 25.86 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.676 0.274 . . . . 0.0 111.131 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -89.02 -25.06 22.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.927 0.394 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.09 -41.72 49.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.059 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.21 -32.96 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.88 -30.35 61.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tt0 -92.82 -22.83 19.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.27 -34.34 64.2 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.58 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.1 pp -85.32 -41.74 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.236 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.726 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 m -62.74 -36.24 82.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.419 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 35' ' ' GLY . 10.7 tp -75.39 -44.12 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.178 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 24' ' ' ILE . 87.0 p -59.67 -56.86 16.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.81 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t -55.91 -42.19 75.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 m -70.23 -22.02 62.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -77.82 -26.89 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.94 -33.73 64.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.219 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 15.7 pt20 -87.0 -20.12 27.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 76.32 -41.85 0.43 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.74 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.31 36.5 0.79 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.655 0.264 . . . . 0.0 111.15 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 50' ' ' ARG . . . -160.79 122.57 1.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.085 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 49' ' ' ASP . 6.7 t -103.25 130.06 50.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.683 ' H ' HD12 ' A' ' 24' ' ' ILE . . . -92.91 111.76 4.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -132.17 159.32 39.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.1 t -95.26 93.39 7.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -173.91 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.41 132.79 11.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -108.35 -85.2 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.34 43.72 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.276 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.22 29.47 56.4 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.982 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.87 148.88 71.21 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.716 0.293 . . . . 0.0 110.992 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 133.99 22.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.605 2.203 . . . . 0.0 112.406 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.4 m -138.21 157.19 46.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.65 98.44 6.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.91 145.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 t -131.33 97.88 4.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.839 ' O ' HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -159.97 121.77 3.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.602 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.6 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 24.4 ttp180 -160.03 28.71 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 t -88.37 125.63 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.47 169.17 6.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.927 -179.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 m -98.1 30.92 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -157.58 143.36 17.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 8' ' ' ALA . 49.6 p90 -106.35 139.32 41.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.7 m -88.55 -54.63 4.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 p -170.61 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 38.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 4' ' ' PHE . . . -57.09 -57.4 12.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' O ' ' CB ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -73.18 -49.24 29.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.822 ' O ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER 83.33 -50.14 0.15 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 p30 43.46 33.16 0.59 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.115 0.483 . . . . 0.0 110.623 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 16' ' ' SER . 29.4 m -127.96 137.13 30.13 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.192 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.7 -61.01 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.697 2.264 . . . . 0.0 112.527 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.89 36.35 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.92 -21.4 12.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.865 ' HB2' HG21 ' A' ' 12' ' ' VAL . 11.2 t -53.29 -25.04 13.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -43.88 65.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.9 t -83.15 -34.09 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -66.81 -26.23 66.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.643 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -92.6 -31.92 14.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.81 -32.76 83.85 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.586 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.6 pp -84.99 -41.6 15.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.747 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.2 m -64.1 -34.82 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.597 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 20' ' ' GLN . 8.0 tp -75.49 -46.74 36.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.475 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.501 ' N ' HG23 ' A' ' 24' ' ' ILE . 16.8 m -66.97 -48.0 69.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 111.232 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -60.64 -42.34 96.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.585 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m -82.47 -14.71 54.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.759 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -81.87 -26.86 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.755 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -24.61 16.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.427 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -17.21 34.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.437 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.0 30.33 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 m -157.61 27.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 50' ' ' ARG . . . -160.57 113.33 0.56 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.027 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 49' ' ' ASP . 11.7 t -97.86 128.66 44.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.71 129.55 9.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.825 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.9 m80 -141.48 118.35 11.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.634 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.7 p -80.0 94.35 5.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.98 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 171.4 9.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.57 131.55 15.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -87.96 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.46 25.99 11.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.376 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 28.27 7.22 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 124.67 26.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.516 0.198 . . . . 0.0 111.048 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.56 86.73 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.5 2.133 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 m -80.06 145.25 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 89.89 3.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 36' ' ' HIS . 30.7 m -80.01 162.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.838 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' THR . 80.2 m -152.52 109.11 3.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.892 ' O ' HG22 ' A' ' 34' ' ' THR . 4.7 t70 -160.0 119.06 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HB2' ' N ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -160.54 35.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 t -92.66 52.56 1.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 161.65 13.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.934 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 3' ' ' ASP . 7.4 p -122.48 -44.34 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.081 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.7 t0 81.85 -13.17 0.9 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.825 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 3' ' ' ASP . 50.3 m-85 -146.68 83.71 1.6 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.3 -66.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m 61.34 76.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.26 44.67 1.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.743 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.21 24.97 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.223 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.82 -51.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 59.9 36.33 21.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.34 40.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.979 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.01 147.02 95.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.681 ' HG2' HD21 ' A' ' 15' ' ' LEU . 18.2 Cg_endo -60.8 -37.96 74.19 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.799 ' C ' HD13 ' A' ' 15' ' ' LEU . . . 145.27 45.1 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.33 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.799 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -135.53 -34.92 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.793 0.297 . . . . 0.0 111.157 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.5 t -56.13 -23.82 36.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.349 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -65.92 -40.94 91.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 22' ' ' LEU . 7.9 t -83.9 -34.06 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.88 -36.35 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 24' ' ' ILE . 3.4 tm0? -90.75 -21.03 21.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.5 -34.33 78.95 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.425 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 23' ' ' CYS . 4.3 pp -85.34 -42.2 14.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.045 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.618 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.7 -34.17 76.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.683 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.18 -46.99 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.021 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 24' ' ' ILE . 45.2 m -63.45 -48.81 76.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -57.4 -49.66 75.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.349 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.77 -13.33 60.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -81.83 -26.62 34.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -36.05 25.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -72.97 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.353 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 64.59 26.62 13.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 111.123 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -153.73 23.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.49 113.38 0.56 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.935 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 49' ' ' ASP . 13.9 t -103.16 134.56 46.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.74 0.305 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.84 130.8 10.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.709 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -139.45 150.95 45.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.92 90.88 5.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -94.54 88.55 5.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.743 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 -178.46 5.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.56 -75.9 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.73 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.23 15.82 58.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.654 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 29.23 2.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -114.39 85.79 11.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.19 92.24 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.532 2.154 . . . . 0.0 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -98.76 144.57 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.68 94.02 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 38' ' ' GLU . 16.8 m -83.11 126.06 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 83.9 m -116.8 104.5 11.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.906 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -154.02 116.0 4.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.634 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.455 ' HB2' ' N ' ' A' ' 34' ' ' THR . 7.8 ttp85 -160.41 28.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.051 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.51 161.09 17.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.842 0.353 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.64 -131.94 1.67 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.915 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.794 0.33 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG11 ' HE2' ' A' ' 17' ' ' LYS . 21.5 t -132.91 133.95 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.79 82.33 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 t80 60.21 99.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.75 98.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.492 ' OG ' HG13 ' A' ' 2' ' ' VAL . 1.2 m -59.94 -34.09 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 m -91.6 -34.07 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.992 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.82 35.87 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -158.47 -42.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 12' ' ' VAL . 1.6 mmm -51.09 -26.04 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.368 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 66.38 44.93 2.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.777 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 16' ' ' SER . 13.2 m -134.48 85.0 38.68 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.71 57.86 5.76 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.699 2.266 . . . . 0.0 112.493 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.732 ' C ' HD13 ' A' ' 15' ' ' LEU . . . -174.21 -43.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.479 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.732 HD13 ' C ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.64 3.73 23.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 12' ' ' VAL . 41.8 p -59.48 -31.39 69.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HE2' HG11 ' A' ' 2' ' ' VAL . 20.9 mttt -83.04 -52.83 6.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.991 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 t -62.92 -37.11 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 22' ' ' LEU . . . -60.4 -30.95 69.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.233 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.577 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -92.04 -23.33 19.53 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.51 -33.38 61.1 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.544 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' CYS . 3.7 pp -84.15 -42.74 15.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -61.1 -41.23 96.3 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.367 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 20' ' ' GLN . 9.6 tp -70.22 -47.86 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.69 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 24' ' ' ILE . 8.6 p -63.65 -55.61 22.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -52.37 -37.97 57.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.207 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 3.7 m -80.44 -22.26 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.314 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 4.8 tptt -73.05 -26.06 61.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.025 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -56.25 -22.34 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.686 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -92.61 -9.87 39.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 56.56 30.07 16.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.197 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 31.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 27' ' ' CYS . . . -161.34 125.52 1.45 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.837 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 49' ' ' ASP . 9.9 t -116.87 135.39 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.687 0.28 . . . . 0.0 110.25 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.44 110.16 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.657 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -119.12 126.45 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 0.0 110.708 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.5 p -80.0 93.7 5.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.87 151.68 19.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.785 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 137.09 9.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.954 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -128.69 -82.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.06 46.95 3.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.318 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.9 31.59 59.88 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -126.69 89.05 53.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.15 124.39 9.5 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.629 2.22 . . . . 0.0 112.325 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 46' ' ' CYS . 49.0 m -130.47 162.36 29.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.427 ' N ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -118.1 100.55 7.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.86 140.18 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.08 93.66 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.92 ' O ' HG22 ' A' ' 34' ' ' THR . 3.1 m-20 -160.35 121.8 3.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB2' ' N ' ' A' ' 34' ' ' THR . 3.7 tmm_? -161.1 60.9 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 m -92.39 149.13 21.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.18 -45.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.504 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.877 -179.957 . . . . . . . . 0 0 . 1 stop_ save_